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“After college, I spent four years in Nigeria teaching at the University of Ibadan. I had the courage 
to venture into an unfamiliar world and thrive there then, as I do now. I was diagnosed April 1, 
2002. And if I had been more aware of symptoms, how to live an healthier life and of the 
possibility of early-onset AD, I could have been diagnosed years earlier.” 
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Introduction: Data from different sources indicate that the number of people with dementia 
of different origins is increasing due to population ageing and improvement on diagnostic 
methodologies. Dementia itself doesn’t discriminate between ethnicities; however, recently 
it was shown differences in dementia risk among ethnicities which may result from 
biological, behavioural, sociocultural, and environmental factors including socioeconomic 
determinants. In Portugal, there aren´t population-based studies about the prevalence and 
characteristics of dementia regarding a specific race or ethnicity. In dementia, central 
autonomic network stations such as the hypothalamus, the amygdala, the insula and locus 
coeruleus are affected in its early stages. Body systems dysfunction due to dysautonomia, a 
failure of the autonomic nervous system, such as cardiac, urinary or thermoregulatory have 
been already reported in dementia investigations but studies on the integrity of the overall 
autonomic function in dementia has been limited and need detailed exploration, in particular 
in cohorts of ethnic patients as the quantification of the differences and the analysis of the 
involved mechanisms can aid in the development of interventions, therapeutics, and public 
policy to reduce and eliminate racial and ethnic differences in dementia. 
Objectives: Within this pilot study, the overall purpose is to investigate autonomic function 
in non-caucasian afrodescendent patients with mild dementia. 
Methods: Non-Caucasian afrodescendent subjects, of both sexes (n=22), aged ≥50 years, 
diagnosed with mild dementia defined in accordance to DSM criteria and after clinical 
diagnosis were enrolled. After anamnesis, clinical history and physical examination, 
autonomic function was assessed through deep-breathing, Valsalva-maneuver and hand-grip 
using time and time-scale methodologies. A group of caucasian subjects with the same 
diagnostic criteria of mild dementia aged >70 years (n=7) and a control group of 
afrodescendent subjects without cognitive impairment (n=12) matching age and sex were 
also included in the study. The participants were recruited and evaluated between February 
2018 and May 2019 at the Neurology Department of Fernando Fonseca Hospital in 
Amadora-Sintra and with the collaboration of CERCITOP, CRL, a semi-public rehabilitation 
and continuing care unit in Algueirão-Sintra, during their first medical appointment 
regarding the complaints of cognitive decline. Participants with atrial fibrillation ablation 
or implantation of a pacemaker diabetes, chronic obstructive pulmonary disease, 
orthostatic hypotension, reflex syncope, cardiac arrhythmias, heart failure, those who had 
undergone cardiac surgery, those who were taken beta-blockers or several psychotropic 
medications such as tricyclic antidepressants, selective serotonin-norepinephrine reuptake 
inhibitors, atypical antidepressants, antipsychotics and cholinesterase inhibitors or have 
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other significant medical causes of dementia (hypothyroidism, chronic subdural hematoma, 
asthma, multiple sclerosis etc.) were excluded from this study. Due to the age of the 
studied population some medications were allowed and included diuretics, peripheral 
acting calcium channel blockers, angiotensin II receptor blockers, serotonin reuptake 
inhibitors and benzodiazepines. Autonomic manoeuvres were evaluated using the Ewing 
battery analysis as well signal processing in which low frequency (LF; 0.04- 015Hz) and high 
frequency powers (HF;.15-0.4Hz) were assessed. The overall autonomic power was 
calculated through the relation LF/HF (mmHg2/ms2). Baroreceptor gain through the 
sequence method and baroreceptor efficacy were also calculated. Paired Student's T test 
and ANOVA “repeated measures" analysis of variance with Bonferroni’s correction were 
applied. A value of p<0.05 was considered statistically significant.  
Results: Patients were divided according to their age distribution: group I: age 
afrodescendent subjects (AfD) of [50-70] years and group II, including two sub-groups of 
AfD and caucasian subjects (CA) aged>70 years. There were no significant differences 
between the groups of individuals in most of the factors that may potentially affect the 
autonomic evaluation. Systolic, diastolic arterial pressures and heart rate, at rest, were not 
different in all groups. Regarding autonomic evaluation, our results show that all patients 
have a lower autonomic tone comparing with controls. In particular, LF and HF show 
statistically significant differences between the groups (p<0.05). Regarding general 
autonomic tone, there is a tendency for its decrease with age, having the AfD patients a 
higher tone than the CA individuals which is in line with the values of resting systolic blood 
pressure. The evaluation of baroreflex sensitivity or gain using the sequence method and 
baroreceptor effectiveness shows an impairment of baroreceptor function in all patient’s 
groups without any significance difference between them. Regarding the autonomic 
manoeuvres, not all the patients were able to perform them at all while others had a 
deficient performance due to difficulty of communication and aging executive problems. 
The maneuver which was better performed was deep breathing probably because it was the 
first maneuver of the evaluation protocol. An additional observation is related to 
neuropsychology assessment to which AfD subjects present lower scores at MMSE (Group I 
AfD: 24,6±1,5; Group II AfD: 23,4±1,8); higher scores at CDR (Group I AfD: 0,7±1,3; Group II 
AfD: 0,9±0,2) and at QSM scale (Group I AfD: 10,5±5,3) which correspond to a more 
pronounced cognitive and functionality impairment of AfD than CA patients. 
Discussion: Both on clinics and in research, autonomic evaluation through power spectral 
analysis is widely used as a way to qualify and quantify autonomic function. In our study we 
used two different ways of evaluating autonomic testing: a time-scale analysis of a basal 
period and system provocative manoeuvres and we noticed that, for this population of 
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patients, the former was more effective in collecting autonomic information than the 
second. Indeed, Valsalva maneuver, deep breathing and handgrip need a high degree of 
motivation and cooperation from the patients which may be difficult in aged and demented 
patients even with mild presentations. This, leads to a strong study limitation of autonomic 
function with provocation in this type of patients to avoid false results, results with no 
consequence and a high rate of drop-outs. We also observed a reduced baroreceptor 
responsiveness accompanying mild dementia. In line with these results, we may 
hypothesize that, in our study, the baroreflex impairment is strongly related to the decrease 
in autonomic function but mainly in sympathetic activity, which was observed in autonomic 
evaluation of the basal period, the VR and the BP changes on phase III of the Valsalva 
manoeuvre and the small rise of diastolic blood pressure during handgrip. However, since 
we worked with a reduced sample size, we need to be cautious regarding this hypothesis. 
Finally, another previous study suggested that baroreceptor reflex sensitivity is more 
sensitive to internal cognitive process during a mental task, while baroreflex effectiveness 
index is more sensitive to external attention process conditions. This suggestion is in line 
with our results, where a generalized decreased in cognitive function is associated to 
baroreflex impairment (both sensitivity and effectiveness) and autonomic dysfunction. 
Whereas baroreflex sensitivity or effectiveness may be used as marker of therapeutic 
efficacy is still a matter of debate but some studies already gave some hints on this 
possibility, because baroreflex is reduced in Alzheimer disease and is influenced by 
autonomic effects of cholinesterase inhibitors. 
Conclusion: This pilot study is the first in Portugal addressing the autonomic function in a 
minority population- the afrodescendent population- suffering from mild dementia. Despite 
being a pilot study, our results show a pathologic pattern in the autonomic regulation in these 
patients evaluated through signal processing and Ewing battery of tests. The importance of 
these results lies on the fact that baroreflex and autonomic impairments, mainly the lack of 
parasympathetic reserve in dementia patients, may be related with the progression of the 
disease or be an inductor of co-morbidities including cardiovascular disease and orthostatic 
intolerance which may lead to falls, dizziness or even syncopal events in these patients. Also, 
baroreflex parameters may be considered as valid biomarkers of disease progression and 
therapeutic efficacy but further research is still needed. 
 







Introdução: Dados de diferentes fontes indicam que o número de pessoas com demência 
de diferentes etnias está a aumentar devido ao envelhecimento da população e à melhoria 
das metodologias de diagnóstico. A demência em si não discrimina entre raças ou etnias 
mas, recentemente, foram mostradas diferenças no risco de demência entre etnias que 
poderá resultar de factores biológicos, comportamentais, socioculturais e ambientais 
incluindo determinantes socioeconómicos. Em Portugal, não existem estudos de base 
populacional sobre a prevalência e características da demência em relação a uma etnia 
específica. Na demência, os centros cerebrais da rede autonómica central como o 
hipotálamo, a amígdala, a ínsula e o locus coeruleus estão afectados nas fases iniciais da 
demência. A disfunção autonómica traduzida por modificações dos sistemas corporais como 
o cardíaco, o urinário ou o termorregulatório já foi abordada em estudos anteriores de 
demência mas, há pouca evidência sobre a integridade da função autonómica geral nesta 
doença, sendo necessária investigação mais detalhada, especialmente em grupos de doentes 
não-caucasianos pois a quantificação das diferenças e a análise dos mecanismos nelas 
envolvidos ajudará nas intervenções médicas, na terapêutica e na modulação das políticas 
públicas no sentido da redução e/ou da eliminação das diferenças étnicas na demência. 
Objetivos: Neste estudo piloto exploratório, o objectivo principal é avaliar e investigar a 
função autonómica de doentes afrodescendentes não-caucasianos com demência ligeira. 
Métodos: Indivíduos afrodescendentes não-caucasianos (n=22), de ambos os sexos, com 
idade ≥50 anos, diagnosticados com demência ligeira de acordo com os critérios do DSM e 
após avaliação clínica que incluiu anamnese e exame físico, foram sujeitos a avaliação 
autonómica por metodologias no domínio do tempo e no tempo-escala aplicadas às 
variáveis fisiológicas recolhidas durante as manobras autonómicas provocatórias de 
respiração profunda, manobra de Valsalva e contracção isométrica. Um grupo de indivíduos 
caucasianos com os mesmos critérios de diagnóstico de demência ligeira (n =7) e um grupo 
controle de indivíduos afrodescendentes sem défice cognitivo (n =12) correspondendo em 
idade e sexo foram igualmente incluídos no estudo. Os participantes foram recrutados e 
avaliados entre fevereiro de 2018 e maio de 2019 durante uma primeira consulta médica de 
neurologia por queixas de declínio cognitivo, no Departamento de Neurologia do Hospital 
Professor Fernando Fonseca, na Amadora, Sintra com a colaboração da CERCITOP, CRL, uma 
unidade de reabilitação de cuidados continuados de Algueirão-Sintra. Os participantes 
sujeitos a ablação de fibrilhação auricular, com pacemaker; doença pulmonar obstrutiva 
crónica; hipotensão ortostática, síncope reflexa, arritmias cardíacas ou insuficiência cardíaca 
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grave, ou submetidos a cirurgia cardíaca, que tomem betabloqueadores ou medicamentos 
psicotrópicos como antidepressivos tricíclicos, inibidores selectivos da recaptação de 
serotonina-norepinefrina, antidepressivos, antipsicóticos e inibidores da 
acetilcolinesterase ou com outras causas médicas indutoras de demência (hipotiroidismo, 
hematoma subdural crónico, asma, esclerose múltipla) foram excluídos do estudo. Devido à 
idade da população estudada, alguns medicamentos foram permitidos e incluíram 
diuréticos, bloqueadores dos canais de cálcio, inibidores da enzima de conversão da 
angiotensina, bloqueadores dos receptores da angiotensina II, inibidores da recaptação de 
serotonina e benzodiazepinas. A avaliação autonómica foi efectuada no domínio do tempo 
através da análise de Ewing e no domínio do tempo-escala no qual a potência das baixas 
(LF; 0.04- 015Hz) e da altas frequências (HF;.15-0.4Hz) foi calculada bem como o tónus 
autonómico total (LF/HF; mmHg2/ms2) e o ganho e a sensibilidade do baroreflexo através 
do método sequencial. O teste T-Student para dados emparelhados e a análise de variância 
através de ANOVA com correção de Bonferroni foram usados para avaliação estatística dos 
resultados tendo-se considerado como estatisticamente significativo um valor de p<0.05. 
Resultados: Os doentes foram divididos de acordo com a sua distribuição etária: grupo I: 
[50-70] anos com indivíduos afrodescendentes (AfD) e grupo II: >70 anos com indivíduos 
AfD e caucasianos (CA). Não houve diferenças significativas entre os grupos de doentes na 
maioria dos factores que podem afetar potencialmente a avaliação autonómica. As pressões 
arteriais sistólica, diastólica e a frequência cardíaca, em repouso, não foram diferentes entre 
os grupos. Em relação à avaliação autonómica, estes resultados mostram que todos os 
doentes apresentam um tónus autonómico mais baixo em comparação aos controles. Em 
particular, LF e HF mostram diferenças estatisticamente significativas entre os grupos (p< 
0,05). Em relação ao tónus autonómico geral, há uma tendência de diminuição com a idade, 
com os doentes AfD a terem um tónus mais alto que os CA, estando estas observações 
alinhadas com os valores da pressão arterial sistólica mais altos observados nos doentes AfD em 
repouso. A avaliação da sensibilidade ou ganho baroreflexo e sua eficácia usando o método 
sequêncial demonstra um comprometimento da função barorreceptora em todos os grupos 
de doentes, sem qualquer diferença significativa entre eles. Em relação às manobras 
autonómicas, nem todos os participantes foram capazes de as executar eficazmente devido 
a dificuldades de comunicação e de coordenação psicomotora própria de doentes com idade 
avançada. A manobra melhor realizada foi a respiração profunda, provavelmente porque foi 
a primeira prova do protocolo de avaliação. Adicionalmente, observou-se que na avaliação 
neuropsicológica, a nível dos critérios clínicos de inclusão, ambos os grupo de doentes 
afrodescendentes revelaram scores mais baixos no MMSE (Grupo I AfD: 24,6 ± 1,5; Grupo II 
AfD: 23,4 ± 1,8); scores mais altos na CDR (Grupo I AfD: 0,7±1,3; Grupo II AfD: 0,9±0,2) e a 
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pontuação mais elevada na escala de QSM (Grupo I AfD: 10,5±5,3) o que corresponde a um 
declínio cognitivo e funcional mais pronunciado, quando comparados com o grupo de 
doentes caucasianos. 
Discussão: Tanto na clínica como na investigação, a avaliação autonómica por meio da 
análise espectral é amplamente utilizada para qualificar e quantificar a função autonómica. 
Neste estudo, utilizamos duas formas diferentes de avaliar o tónus autonómico: uma análise 
no dominio tempo-escala e manobras provocatórias autonómicas. Com elas, observámos  
que, para esta população de doentes, o primeiro era mais eficaz na recolha de informações 
autonómicas do que o segundo. De facto, a manobra de Valsalva, a respiração profunda e a 
contracção isométrica precisam de um maior grau de motivação e cooperação dos doentes, 
o que pode ser difícil em doentes idosos e dementes, mesmo com apresentações ligeiras dos 
sintomas da doença, sendo esta uma forte limitação neste tipo de estudos. Também, foi 
observada uma reduzida capacidade de resposta do reflexo barorreceptor nestes doentes 
com demência ligeira comparativamente aos controlos saudáveis. De acordo com esses 
resultados poderemos colocar a hipótese que, no nosso estudo, o comprometimento da 
resposta barorreflexa esteja fortemente relacionada com a diminuição da função 
autonómica simpática, como foi observado na avaliação autonómica no período basal, bem 
como através do atraso da manobra de Valsalva e o reduzido aumento da pressão arterial 
diastólica durante a prova de contracção isométrica. No entanto devido ao tamanho 
reduzido da amostra conseguida, teremos que ser cuidadosos na formulação desta hipótese. 
De referir, também, que estudos anteriores sugerem que a sensibilidade do reflexo barorreceptor 
é permeável ao processamento mental (interno) durante tarefas cognitivas e que o índice de 
eficácia barorreflexa é mais sensível a estados mentais de processamento de atenção visual 
externa. Estas evidencias parecem estar concordantes com os nossos resultados, nos quais se 
verifica uma diminuição generalizada da função cognitiva associada ao comprometimento 
barorreflexo, quer da sensibilidade (BRS) quer da eficácia (BEI), e a disfunção autonómica. 
Considerando que o BRS e/ou BEI possam ser usados como biomarcadores de eficácia 
terapêutica é motivo de debate, embora, alguns estudos já evidenciaram resultados sobre essa 
possibilidade, porque o baroreflexo está reduzido na doença de Alzheimer (que origina um dos 
tipos de demência) e é influenciado pelos efeitos autonómicos dos inibidores da colinesterase.  
Conclusão: Este estudo piloto é o primeiro em Portugal a abordar a função autonómica 
numa população minoritária - a população afrodescendente - com diagnóstico de demência 
ligeira. Apesar de ser ainda um estudo piloto exploratório, os resultados obtidos mostram 
um padrão patológico na regulação autonómica dos doentes avaliados através do 
processamento de sinal no dominio do tempo-escala e da bateria de testes de Ewing. A 
importância destes resultados reside no facto de que as alterações barorreflexas e 
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autonómicas podem estar relacionadas com a progressão da doença ou serem indutoras de 
comorbidades, incluindo doenças cardiovasculares e intolerância ortostática, que podem 
levar a quedas, tonturas ou mesmo a eventos sincopais nestes doentes. Além disso, o BRS 
e/ou o BEI podem ser considerados como biomarcadores válidos da progressão da doença  
e da eficácia terapêutica, mas são necessárias mais investigações futuras. 
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1.1 General Overview of Dementia 
 
1.1.1 Definition of Dementia 
 
Dementia rather than a specific disease should be considered as a syndrome, of a chronic or 
continuous nature, in which there is decline in cognitive function beyond what might be 
expected from normal ageing affecting memory, thinking, orientation, comprehension, 
calculation, learning capacity, language, and judgement and leading to a reduction of the 
individual’s ability to perform everyday activities (WHO, 2015). But also, a cognitive 
decrease in normal aging is expected and may increase reaction times among the healthy 
aged. For this reason, it is already known that the degree of intellectual competences in the 
elderly population is itself varied, which can lead to the misdiagnosis of dementia in 
individuals of poor intelligence (Gurland, 1981). 
 
In current clinical practice the diagnosis of dementia is decided on the basis of a set of key 
clinical, histopathological and localization factores. According to The Diagnostic and 
Statistical Manual of the American Psychiatric Association (DSM, 2013), the diagnostic 
criteria for dementia are a demonstrable impairment in short-term and long-term memory; 
the ability of memory/cognitive impairment to interfere with work, social activities and 
relationships; evidence of an organic factor that is “aetiologically related” to the 
disturbance; and at least one of the following: abstract thinking impairment; impaired 
judgement; aphasia; apraxia; agnosia or personality change. But further differentiation of 
diagnosis can be made by considering the site and the histology of the dementia (these two 
factors help to determine which type of dementia the patient is exhibiting). 
 
Histopathology is probably the criteria that is least susceptible to interpretation, because 
the molecular and biochemical evidence is clear-cut. Because of this, the only certain 




1.1.2 Clinical Classification of Dementia 
 
The DSM lists the main clinical and behavioral symptoms that should appear in order to 




(a) dementia of the Alzheimer type; 
(b) vascular dementia (or due to Stroke); 
(c) dementia due to Parkinson`s disease or Lewy-body dementia; 
(d) dementia due to Huntington’s disease; 
(e) dementia due to Pick`s disease or Frontotemporal dementia; 
(f) dementia due to Creutzfeldt-Jakob disease; 
(g) dementia due to HIV disease; 
(h) dementia due to head trauma (eg.: TBI); 
(i) dementia due to other general medical conditions; 
(j) substance-induce persisting dementia; 
(k) dementia due to multiple aetiologies; 
(l) dementia not otherwise specified 
 
 
Different types of dementia affect different brain systems and reveal slightly different clinical 
symptoms. The most prevalent subtype of dementia is Alzheimer disease (AD) with more 
than 50% of cases and three outlined phases: pre-clinical AD when the disease is present in 
the brain but there are no symptoms; mild cognitive impairment (MCI) due to AD (also 
called prodromal AD) and dementia caused by AD. The dementia caused by AD involves 
memory, thinking and behavioral symptoms that impair a person’s ability to function in 
daily life and can be further clinically classified as probable (to be diagnosed when the 
person meets all the core clinical criteria),  possible (to be diagnosed when there is an atypical 
or mixed presentation) and probable or possible Alzheimer’s disease dementia with evidence 
of the Alzheimer’s disease pathological process which is to be diagnosed when there is 
biomarker evidence that will increase the certainty that the presented dementia is due to 
Alzheimer’s disease. The AD was named after Alois Alzheimer who in 1907 reported the 
case of a 56-year-old patient with abnormal formations called presenile plaques tangle in 
her brain. She exhibited an obvious form of present dementia, to which Alzheimer gave his 
name. In addition to Alzheimer's disease are other dementia subtypes, the most second 
common being vascular dementia (Roman et al., 1993) and other types of dementia are 
frontotemporal dementia (Neary et al., 1998) and dementia with Lewy bodies associated 
with Parkinsonism (McKeith et al., 2006). 
 
In general clinical practice, the degree of any subtype of dementia can be classified into mild; 
moderate or severe depending on the level of functional dependence and behavioral 
disturbance (MacKhann et al., 1984; Nitrini et al., 2005) with the possible or probable clinical 
diagnosis of Alzheimer's disease according to the last revision criteria in 2007 of NINCDS-
ADRDA (Dubois, 2007). All these dementia clinical criteria and its different etiologies or 
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subtypes for differential diagnosis can be found in the last 2011 Clinical Health Directorate 
General Publication (DGS, 2011) and compiled in the latest 5th DSM version (DSM-V, 2013). 
 
 
1.1.3 Epidemiology of Dementia 
 
The World Health Organization (WHO, 2015) estimates that there are 47.5 million people 
with dementia worldwide, up to 75.6 million by 2030 and nearly tripling by 2050 to 135.5 
million. In this context, Alzheimer's disease takes a prominent place, representing about 60 
to 70% of all dementia cases. In Portugal, since there is not yet a nationally updated 
epidemiological study that portrays the real situation of the problem, we can refer to the 
Alzheimer Europe (2014) data that point to about 182 thousand people with dementia. On 
the other hand, in the OECD (2017) Health at a Glance Report published on 10 November 
2017, new data on the prevalence of dementia are presented, making Portugal the 4th 
country with the most cases/per thousand inhabitants. 
 
The OECD average is 14.8 cases per thousand inhabitants. The estimates for Portugal reach 
over 205,000 people, and will rise to 322,000 cases by 2037. The Portuguese population over 
65 years in 2009 reached 19.1%, the average life expectancy at birth was 2012 of 82.5 years 
for women and 77.3 years for men (INE, 2009) and the prevalence of cognitive impairment 
is 12.3% and 2.7% of dementia between 55 and 79 years old, being higher in elders (DGS, 
2011). But specific epidemiological data in Portugal are sparse and a population-based 
studies about the prevalence and characteristics of dementia concerning a specific race or 
ethnicity that focused on clinical diagnosis coding in primary health care on a particular 
region, have not been conducted. 
 
Age is the main risk factor for dementia and increase the prevalence rate. Between 65 and 
69 the prevalence rate is 2%, rising to 4% between 70 and 74, 7% between 75 and 79, 12% 
between 80 and 84 and 20 % between 85 and 89. For people over 90 years of age, the 
prevalence rate is 41% (OECD, 2017).  
 
According to the OECD (2017) report, the average number of people with dementia is 14.8 
cases per thousand inhabitants and for Portugal the estimate is 19.9, which corresponds to 
more than 205,000 cases and until 2037 about 322 thousand cases. 
 
As we already mentioned the most common type of dementia is Alzheimer's disease, which 
makes up 50% to of cases. Other common types include vascular dementia (25%), dementia 
with Lewy bodies (15%) and Frontotemporal dementia (WHO 2019). Less common causes 
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include Normal Pressure Hydrocephalus, Parkinson`s disease; Syphilis; HIV and 
Creutzfeldt-Jakob disease (Santana et al., 2015). But interesting is the fact that a very recent 
Portuguese study conducted by Ruano and his collaborators (2019) in a cohort of patients 
from the northern regions of the country suggested that the main cause of dementia in 
Portugal is related to vascular factors, contrary to what happens in most western European 
countries. They evaluated the prevalence of cognitive impairment and dementia in a sample 
of 730 individuals and attempted to identify their most frequent causes. The results show 
that about 4.5% of individuals over 55 years have mild dementia or cognitive impairment 
and that the most prevalent type of dementia is vascular dementia. The high incidence of 
stroke in Portugal is a risk factor compared to other countries, which may explain this 
tendency for the development of this type of dementia. On the other hand, Portugal is the 
European country with the highest consumption of fatty fish, which seems to be associated 
with a lower risk of Alzheimer's dementia and there is a lower prevalence among the 
Portuguese population of the APOE ε4 allele, the most common genetic risk factor for 
Alzheimer's disease (Ruano et al., 2019). Additionally, it is known that vascular dementia 
can be prevented by lifestyle modification, so primary prevention measures such as healthy 
diet, regular exercise and control of major cardiovascular risk factors (Pannain et al., 2019). 
In previous studies it also has been shown that Physical activity may protect against 
dementia risk through several mechanisms that facilitates learning, increasing the 
expression of genes promoting neurogenesis and neural plasticity (Podewils et al., 2005). 
 
Other epidemiological studies by the nature of their community sampling have been able to 
study risk for AD in racially representative populations. In such studies, older African- 
Americans have been reported as being more likely than older Caucasians to develop AD 
and other dementias two or three times higher (Gurland et al., 1999; Dilworth-Anderson et 
al., 2008; Potter et al., 2009; Barnes and Bennett, 2014; Alzheimer's Association, 2015). 
These data are complemented with others from a recent study (Chen & Zissimopoulos, 
2018) who showed the importance of quantifying the interethnic differences of dementia 
and of understanding its mechanisms to contribute for the development and 
implementation of interventions, therapeutics, and  to tackle public policies for reducing 
and eliminating racial and ethnic differences in dementia. 
 
By 2050, according to The Alzheimer's Association annual report (2010), the proportion of 
racial minorities with AD will increase from 20 to 42%, with African-Americans increasing 
from 9 to 12%. A more recent report suggests that 16% of African-Americans were 
diagnosed with AD or other dementias compared to 8% of Caucasians (Alzheimer's 
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Association, 2015). In another study of Tuerk & Sauer (2015), African-Caribbean patients 
were diagnosed with dementia on average 4.5 years younger than their White british 
counterparts and were more likely to be diagnosed with a vascular or mixed type dementia. 
The scores on initial cognitive testing were significantly lower in the African-Caribbean 
group, possibly representing more advanced disease at presentation. In 2010, according to 
the United Kingdom national development strategy for dementia (Banerjee, 2010), the 
number and proportion of afrodescendent and minority ethnic people with dementia was 
set to increase sharply over the next years. A survey of clinical dementia centers across 
Europe found varying levels of access by this specific group of patients and that where these 
patients did access services, diagnostic evaluation was more challenging owing to language 
barriers and the availability only of cognitive assessment tools validated in Western cultures 
(Nielsen et al., 2011).  Older Chinese and Vietnamese patients in Australia were believed to 
present to memory services at a more advanced stage of cognitive impairment because 
linguistic and cultural complexities may have contributed to longer waits for diagnosis in 
primary care (Lee et al., 2011). Afrodescendent and minority ethnic people with dementia 
populations were diagnosed with dementia at an earlier age in one Danish study (Nielsen et 
al., 2011) and similar barriers to help-seeking for careers patients with dementia were 
evident in research from both Australia and the USA. These studies emphasize the 
importance of the international recognition of the growing need for culturally sensitive 
memory services in USA, Australia and Europe (Haralambous et al., 2014). Also, several 
studies have been linked the decrease of dementia risk with the improvement of 
cardiovascular health and the rise of educational levels (Chen & Zissimopoulos, 2018) 
suggesting that racial and ethnic disparities in dementia prevalence might change over time 
depending on both changes in risk factors and variation in their relative impact for the 
various ethnic groups. 
 
 
1.1.4 Diagnostic and Clinical characteristics 
 
The diagnostic criteria for dementia incorporate the scientific knowledge and technological 
advances gained in recent times and reflects the contemporary state of understanding 
regarding the detection and diagnosis of dementia and related disorders characterized by 
cognitive impairment. Dementia, especially AD, has emerged as one of the biggest threats to 
public health and personal wellbeing among older adults. In 2011, the National Institute on 
Aging and the Alzheimer’s Association published new diagnostic guidelines for this disease 





Also in 2013, the American Psychiatric Association published the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-V) that is similar to the DSM-
IV-R but due to this new clinical criteria value Dementia was renamed ‘major 
neurocognitive disorder’ and also recognizes earlier stages of cognitive decline as ‘mild 
neurocognitive disorder’. Another clinical reference diagnostic guideline is the International 
Classification of Diseases published ICD-11 by the World Health Organization in June 2018. 
ICD-11 adopted the terminology ‘neurodevelopmental disorders’ and very similar 
diagnostic criteria to those of the DSM. The aims of all this reclassification is for reducing 
stigma associated with dementia and bringing the diagnostic guidelines into line with 
current clinical practice. However, the term dementia may still be used as an acceptable 
alternative. 
 
Therefore, the general diagnostic criteria for dementia is characterized by ‘major 
neurocognitive’ (NCD) acquired deficits, which represent a decline from previous 
functioning, rather than neurodevelopmental deficits present from birth or early life. There 
are 6 (six) cognitive domains which may be affected in both MCI and Dementia: (1) Complex 
attention and information processing speed; (2) Executive function, decision making, mental 
flexibility and working memory; (3) Memory and Learning; (4) Language; (5) Perceptual-
motor function and (6) Social cognition, which includes recognition of emotions, theory of 
mind and insight. The specific criteria for differential diagnosis of subtypes of dementia is 
based on examination of potential etiology causes. In many cases there is evidence of a 
causative disorder, such as Stroke and TBI; Huntington’s disease or HIV infection. In others, 
the cognitive symptoms emerge first and progression provides evidence of a causative 
disorder such as AD or Lewy body disease. In many cases, especially for older people, there 
are multiple causative factors, and the diagnosis should recognize this. And there is an 
increasing understanding that other cognitive domains not only memory, such as language 
or attention, may be impaired first, or exclusively, depending on which parts of the brain 
are affected by the underlying disease. 
 
1.1.5 Clinical Assessment 
 
Clinical evaluation in the diagnosis of dementia may be performed in a memory consultation 
with a neurologist and a neuropsychologist with objective observation; record of clinical and 
family history with the main complaints and time of evolution of the first symptoms. 
Additionally, more specific neurological and neuropsychological examinations may be 
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requested, such as neuropsychological assessment neuroimaging or neurophysiological 
examinations; blood tests or genetic tests. In general, portuguese public hospitals are not 
routinely requiring autonomic examination of dementia patients unless there are clinical 
suspicions of a serious autonomic failure. In addition, the number of professionals with the 
appropriate competences to perform a credible autonomic evaluation is very small. 
 
Regarding quantitative neurocognitive assessment based on psychometrics, there is the 
neuropsychological assessment that uses quantitative and qualitative techniques in the 
form of standardized batteries (Beaumont, 2008; Kolb & Whishaw, 2003). The cognitive 
deficit diagnosis is based on the comparison between the results of the subject and those of 
normative subjects (D'Amato & Hartlage, 2008). This type of higher nervous functions 
examination is a noninvasive functional examination that measures brain activation of 
diverse neurocognitive and neurobehavioral domains based on performance in qualifiable 
psychometric tests with a qualitative assessment of the functional autonomy level of the 
patients and their quality of life. 
 
According to the Portuguese Psychology Association (2019) based on the American 
Psychology Association definitions, neuropsychology is a scientific area that researches the 
multiple relations between cognitive and mental functioning, its neurobiological correlates 
and the behavior of the individual in different contexts and phases of the life cycle. 
Neuropsychology uses a variety of methods and techniques from Psychology and 
Neuroscience, being a specialty of clinical and health psychology implemented in the 
Portuguese national health service at central acute hospitals and in primary health care 
units. 
 
The development of methods and techniques in neuropsychology for assessment, diagnosis 
and intervention was widely stimulated during the period that comprised the two great wars 
(1914-1945) for the need to create neuropsychological rehabilitation programs for military 
victims of brain injury such as stroke and TBI (Kolb & Whishaw  2003; Lezak 2004). The 
20th and 21st centuries have contributed to the clinical neuropsychology field through the 
development of functional neuroimaging, the integrated brain and mind research and by 
urging the implementation of public health policies on aging and mental-health care (Kolb 
& Whisahaw, 2003).  
 
There are tests and scales for neuropsychological evaluation specifically translated and 
validated for the Portuguese population as recommended since 2011, by DGS. These 
measurement instruments take into account socio-demographic factors such as age; 
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education and culture. The most common and reliable neuropsychological screening tests 
used in Portuguese clinical practice include the Mini Mental-State Examination (MMSE 
Folstein, Folstein, & McHugh, 1975), the Washington University Clinical Dementia Rating 
Scale (CDR; Morris, 1993) and the Subject Memory Complains questionnaire (QSM; Schmand 
et al. 1996; Ginó et al., 2007) which application to designed patients are useful both to 
clinical diagnosis, to clinical trials and dementia research. 
 
In the field of cognitive trait tests, MMSE has a scale score ranging from 0 to 30 with higher 
scores indicating a better cognition. This scale has six subdomains each of them as a certain 
sub-score rating, which includes orientation (10 points maximum), retention (3 points maxi- 
mum), attention and calculation (5points maximum), deferred evocation/recall retention (3 
points maximum), language (8 points maximum) and visual-constructive ability (1 point 
maximum). The norms in this instrument have been successively improved by considering 
variables such as age and schooling, both influencing MMSE scores, as well as, the definition 
of cut-off points (Guerreiro et al., 1994; Morgado et al, 2009; Freitas, Alves & Santana, 2012). 
MMSE is a valid tool for frequent diagnosis of mild cognitive impairment or other forms of 
dementia, used in consultations specializing in different levels of health care, and is more 
sensitive to AD screening (Santana et al., 2016) but it should be emphasized that a high 
MMSE score does not exclude the possibility of dementia.  
 
CDR is a global assessment instrument that yields global boxes scores used in clinical and 
research settings for staging dementia severity. Is a 5-point scale used to characterize six 
domains of cognitive and functional performance - Memory, Orientation, Judgment & 
Problem Solving, Community Affairs, Home & Hobbies and Personal Care- applicable to 
Alzheimer disease and related dementias. The needed information to achieve each rating is 
obtained through a semi-structured interview of the patient and a reliable informant or 
collateral source (e.g. family member) referred to as the CDR Assessment Protocol with 
previous revision criteria (Tractenberg et al., 2011). The CDR scoring provides descriptive 
anchors which guide the clinician in making appropriate ratings based on interview data and 
clinical judgment. In addition to ratings for each domain, an overall global CDR score may 
be calculated through the use of an appropriate algorithm. CDR scores are useful for 
characterizing and tracking patient's level of impairment/dementia: 0 =Normal; 0.5 =Very 
Mild Dementia; 1 =Mild Dementia; 2 =Moderate Dementia and 3 =Severe Dementia. CDR global 
score has several advantages for detection of dementia among healthy elderly, being a 
reliable diagnostic standard measure (Chaves et al., 2007) and can accurately diagnosis MCI 




The subjective memory complaints are an important clinical factor and a frequent problem 
in primary health care in adult and older people (Eichler et al., 2015). The relationship 
between subjective perception of memory and performance in objective tests has been 
widely investigated given its clinical relevance in the diagnosis of cognitive impairment with 
significant partial correlations found in tasks related to working memory, verbal episodic 
memory, and long-term semantic memory providing additional evidence of the clinical 
relevance of the subjective perception of memory evaluation (Bourscheid; Mothes & 
Irigaray, 2016). For that reason, QSM is a clinical tool that investigates subjective memory 
complaints that represent a type of concern made by people with cognitive difficulties, very 
common in elderly individuals (Young et al. 200). For example, in community-based studies, 
their reported prevalence was 25%-50%, and more than half of elderly individuals with 
subjective memory complaints were worried about incipient dementia, specifically, AD 
(Mitchell et al. 2008). This questionnaire has ten questions, and the scoring of each item on 
the scale ranges from 0 (zero), 1 (one), 2 (two) or 3 (three) points depending on the type 
and severity of the complaint, can reach a maximum of 21 points. For the Portuguese 
population values greater than or equal to 4 points are indicative of the presence of 
significant memory complaints. In a longitudinal study carried out in a primary health 
care of the Central Region of Portugal, to characterize the QSM according to socio- 
demographic, clinical, cognitive, emotional and quality of life variables, was demonstrated 
that subjective memory complaints might be an important symptom for the early 




1.1.6 Prognosis and its relation to ageing 
 
The causes of aging can be related to some damage concept theories whereby the 
accumulation of damage such as DNA oxidation may cause biological systems to fail 
(Burrows & Muller, 1998) or to the programmed aging concept, whereby internal processes 
such as DNA methylation may cause ageing (Evans & Evans, 1970).  
In humans, ageing represents the process of becoming older and, therefore, the accumulation 
of changes along time encompasses physical, psychological and social modifications. Ageing is 
a condition of functional vulnerability that can lead to disease resulting from structural or 
functional disturbances due to internal or external causes, as the body and the brain grow 
older (Hayflick, 2000). Aging is the greatest known risk factors for most human diseases. 
Therefore, age has been also identified as the strongest risk factor for AD, the most prevalent 
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form of dementia as it is predominantly a disorder of later life.  
 
Beyond old age, ageing and dementia are also associated strongly with some demographic, 
co-morbidities and lifestyle risk factors related to the onset symptoms of the 
neurodegenerative pathologies, such as: being a woman, low education and low social class; 
diabetes, vascular disease, stroke, hypertension, depression, smoking and reduced physical 
activity (Wu et al. 2016). But, there are numerous biopathological and cognitive-behavioral 
changes which are associated with normal ageing, being many of these the same as the 
changes attributed to dementia. For this reason, we can assume that physiological changes 
due to dementia can be confounded with age-related changes. On the other hand, it seems 
consensual that normal ageing and dementia are a continuum, the changes differing in 
degree but not in kind (Huppert, Brayne & O`Connor, 1994). 
 
At a neurocognitive level there is a decline in various functions such as the manipulation of 
information in working-memory, retrieval of names, reaction time, declarative memory and 
information processing. And, these cognitive impairments – also the normal deterioration 
observed in ageing - can be misled with the symptoms of dementia, and there is great debate 
over whether dementia is simply an extension of old age or a disorder that is separate from 
it. 
 
Therefore, ageing mechanisms may be more pronounced in patients with dementia due to 
the occurrence of dysfunctions in cerebral structures that coordinate visceral functions 
such as the cardiovascular, digestive and respiratory ones which are also part of the central 
autonomic network. At cardiovascular level, new specific studies (Lane et al., 2019) using 
also neuropsychology assessment with cognition performing tasks and positron-emission 
tomography-MRI scanner, suggest that continuous high blood pressure and sudden 
increases in BP are associated with brain pathologies in later life like the increase of white 
matter hyperintensity and smaller brain volumes. Having high blood pressure would also 




1.1.7 Therapeutic approaches 
 
The dementia treatments attempt on alleviating the impairment of memory. The 
neuropharmacological treatment may lead to some improvement in cognitive memory 
performance (Cameron et al., 2000; Evans et al., 2003) and functional abilities with more 
participation in daily activities and therefore a reduce of total costs and time spent by 
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patient and caregivers (Reisberg et al., 2003). The cholinergic hypothesis of AD led to drug 
development that specifically sought to redress the loss of cholinergic neurons and 
neurotransmitters. The mechanism of action for these drugs is the inhibition of the enzyme 
acetylcholinesterase (Winblad et al., 2016) and the role of the cholinergic system in memory 
was encouraged by studies in which scopolamine, a cholinergic antagonist, produced 
amnesia in healthy individuals. Scopolamine was normally administrated with analgesia 
during surgery; women in labor would report not being able to recall events during the 
delivery when they were given scopolamine (Thal, 1992). 
Based on effects of scopolamine on both neurochemistry and cognition, work began into 
developing new drugs that would prolong the action of acetylcholine. One of such drugs, 
physostigmine, appeared to have a significant positive affect on verbal and non-verbal 
memory when given intravenously (Christie et al., 1981). Another one, 
tetrahydroaminoacridine, also appears to produce improvements in verbal memory (Kaye 
et al., 1982). However, the response to these and other drugs can be variable due to a number 
of psychopharmacological factors, among them the fact that some agents are poorly 
absorbed, do not cross the blood-brain barrier and have severe side-effects. Currently, the 
specific and potent clinical acetylcholinesterase inhibitors most commonly used are 
donepezil, rivastigmine and galantamine, for the treatment of mild and moderate dementia. 
Memantine, a non-competitive agonist of N-methyl-D-aspartate receptors has been used in 
the treatment of moderate to severe Alzheimer disease. Other drugs under review are the 
anti-inflammatory ones, because the incidence of AD is low in sufferers of rheumatoid 
arthritis who are taken them and antioxidants such as vitamin-E. However, none of them 
has been shown to demonstrate consistent therapeutic efficacy (Bulock, 2002). Another 
putative treatment currently under investigation involves the removal of the amyloid 
protein. 
 
Also non-pharmacological measures introduced in the prevention and rehabilitation of 
dementia has been shown to be effective when combined with drug administration. These 
include the psychological and psychotherapeutic support, the psychoeducation and the 
cognitive intervention adjusted to a healthy and neuroprotective lifestyle. There is 
consistent evidence from multiple clinical trials that programmes of cognitive stimulation 
consistently benefit cognition in people with mild to moderate dementia over and above 
any medication effects (Woods et al., 2012). Cognitive stimulation is also associated with 
increase of patients quality of life, well-being and communication in addition to any 
medication effects (Aguirre et al., 2013). However, other outcomes need more exploration 
to reinforce the potential benefits of longer-term cognitive stimulation programmes and to 
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strength their clinical significance. 
 
1.1.8 Impact of dementia on Quality of Life 
 
Dementia is receiving increasing attention from governments and politicians. 
Epidemiological research based on western European populations done 20 years ago 
provided key initial evidence for the dementia policy making, but these estimates are now 
out of date because of changes in life expectancy, living conditions and health profiles (Wu 
et al., 2016). Although life expectancy at birth continues to show substantial variation 
between social environments across countries, previous research shows that combined 
prevalence estimates in western Europe are reasonably consistent across countries 
(Hofman et al., 1991). But the trends in prevalence and incidence of dementia are likely to 
be modulated by a complex combination of societal changes affecting survival, lifestyle 
factors, cultural, genetic and health profiles across life stages. 
 
In Portugal, the economic, social and psychological costs for the families of patients with 
dementia are very high. Together with the ability of the institutionalization of patients in 
nursing homes, some specialized rehabilitation dementia units of the Portuguese national 
health system, applying neurocognitive-behavioural rehabilitation and socio-occupational 
reintegration programs whenever possible, are starting to be developed to support these 
patients and their families. There is also the Portugal Alzheimer Association a private 
institution social solidarity founded in 1988 by Professor Carlos Garcia (1936- 2004), a 
nationwide organization, that highly promotes the quality of life of people with dementia. 
 
Although public awareness about dementia is increasing it is still limited, being necessary to 
improve the literacy about it as well as social education. In fact, there is still a great lack of 
knowledge regarding the signs and early symptoms of dementia and the responses for the 
diagnose and intervention process in the community are very limited. False beliefs, stigmas 
and unconstructive attitudes associated with dementia still persist and adversely affect the 
patients and their caregivers’ quality of life (Wu et al., 2016). Several studies have shown 
differences on morbidity among elderly patients with dementia of different ethnicities and 
cultures, on the prevalence of behavioral and neuropsychiatric symptoms, on how 
education and the belief system influence the cognitive changes experienced by the patients 
themselves and on the time-point when patients seek help from the health services for 
diagnosis and treatment (Wykle et al., 1991; Sink et al., 2004; Gillum et al., 2011; Mukadam 




In Portugal, until the present, we are not aware of any study in ethnic communities regarding 
patients quality of life despite some differences between white and afrodescendent caregivers 
in the cope strategies with distress have been reported in others international studies 
(Kneebone et al., 2003; Broday et al., 2009 and Pinquart et al., 2005). The relationship 
between ethnicity, race and dementia in epidemiological perspective can be influenced by 
cultural factors more or less protective related to symptom management, as they may 
influence the way how patients and their family’s value and recognize the progression of 
the disease. On the other hand, ethnic or racial differences are often associated with 
immigration phenomena, education level, beliefs and socioeconomic status. Patients with 
dementia and their caregivers may also use different languages, religious beliefs or cultural 
practices distinct from those in health services, which may constitute itself a social minority 
group segregation and a barrier to access the appropriate treatment (Lliffe et al., 2004). 
 
Lifestyle factors, identified as diet, physical activity and sleep hygiene, play an important 
role in the development, progression and treatment of dementia as they are closely link to 
dementia risk factors. A recent report from Alzheimer Association refers that around 1/3 of 
the dementia cases can be prevented by introducing lifestyle measures in the patient daily 
life which are inexpensive comparing with the pharmacological therapeutics (Lancet, 
Alzheimer research UK). In fact, not smoking, doing exercise, keeping a healthy weight, 
treating high blood pressure and diabetes together with nutritional counselling can all 
reduce the risk of dementia (Alzheimer Research UK). Despite needing more evidence, 
additional measures of social and cognitive stimulation, mood changes evaluation and 
improved self-management may also help cognitive function improving this patient’s 
quality of life (Alzheimer Research UK). 
 
In a way to find new clinical approaches and a close relation between the clinical teams, the 
patients and their families/caregivers, personal health systems for the management of 
progressive diseases have been developed under the recent years both as research 
prototypes (e.g. EU funded MyHeart, Heart Cycle, Metabo projects) and commercial products 
(e.g. Philips Motiva or IntelGE Care Innovations guide). These solutions offer vital signs 
monitoring and therapy delivery at home but focusing on physical conditions rather on 
providing support for cognitive or psychological treatment which is still lacking. 
 
 
1.1.9 Health economics related to dementia 
 
The national and global economic and social impacts due to the prevalence of dementia in 
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ageing have been an incentive for the pursuit of innovative treatments based on clinical 
research especially on multicenter clinical trial methodology. For instance, the current cost 
of caring patients with dementia Alzheimer’s treatment in the UK alone is estimated to be 
between 6 billion € and 16 billion € per year (McNamee et al., 2001; Lowin et al., 2001), but 
no current treatment is able to halt the progress of AD. A recent USA study, the CARE study (= 
Costs, Accountabilities, Realities and Expectations) promoted by the Northwest Mutual 
Insurance indicated that caregivers in the USA are spending more money on caring than it 
was financially planed. This study found that 7 in 10 caregivers reported lowering their own 
spending to be able to pay for caregiving costs for a parent or senior loved-one. Data from 
the study were gathered from online surveys among 1,004 adults, aged ≥18. The 
demographics of the people polled included over 200 persons aged 35-49 and just over 700 
experienced caregivers. The report was published in March of 2018. About the cost of 
Dementia Care report include the following facts and figures: 
 
1. 67% of caregivers reported reducing their own living expenses to pay for 
caregiving costs (this number was up from 51% last year); 
2. 57% of future caregivers expect to have personal costs of providing care, but 
48% have not planned financially (a jump from only 35% last year); 
3. 53% of American caregivers say the caregiving situation was not planned and 
many were financially unprepared for the event; 
4. Only 48% of caregivers reported that they were financially ready to provide 
financial support; 
5. 34% of current caregivers report their monthly spending on caregiving-
related expenses is between 21-100% of their budget. 
 
Another report from the Alzheimer’s Association further tackles this point by detailing the 
cost of dementia care in the USA and its impact on families: 
 
• In 2017, 18.4 billion hours of care, valued at $232 billion, were provided by 
the family and unpaid caregivers; 
• 83% of the help provided to older adults in the USA come from family 
members, friends and other unpaid caregivers; 
• The total lifetime cost of care for someone with dementia is estimated to be 
$341,840, with the costs associated with family care to be 70% of lifetime 
dementia care costs; 




In 2013, the authors of the World Alzheimer Report estimated that 44 million people were 
having dementia worldwide, causing a substantial economic cost for the overall society. In 
2017, was estimated that the total economic costs due to dementia increased from US$279 
billion in 2000 to $948 billion in 2016, with an annual growth rate of 15%. This included 
costs of informal care at $95 billion in 2000 and $401 billion in 2016, with the annual growth 
rate of 21%. Regional differences in the economic burden of dementia exist, and the highest 
economic burden was found in Europe and North America (Xu et al. 2017). For that, 
dementia is a substantial economic burden worldwide and a global and regional strategic 
action plan for dementia will be important to be followed to reduce the future burden of 
dementia. 
 
In Portugal, the estimated number of people with dementia among those aged ≥ 60 years, is 
160.287, representing 5.91% of this population-stratum. Knowing Alzheimer’s disease is 
responsible for 50-70% of all cases, we might conclude there are between 80144 and 
112201 patients. According to a recent population-based study, 76250 receive anti-
dementia drugs and the costs of this kind of medication is 37 M€/year (Santana et al. 2015). 
And apparently, not all Alzheimer’s disease patients receive the recommended medication, 
suggesting that this condition is still under-diagnosed. However, figures indicate a positive 
progression with an increment of treated cases and a reduction of medication-costs 







1.2. Pathophysiology of Dementia: major pathophysiological and neuropathological 
mechanisms 
 
Alzheimer's disease presently is the commonest cause in the developed world, causing a 
cortical-subcortical degeneration of ascending cholinergic neurons and large pyramidal cells 
in the cerebral cortex. Clinically, the disease reflects predominantly deterioration of function 
in the association cortex. Pharmacologically and pathologically, abnormalities are more 
diffuse and extend into sensorimotor cortical areas as well. 
 
Post mortem, the brains of AD patients show shrinkage primarily of the frontal and temporal 
gyri (up to 20%) and ventricle enlargement. There is the possibility that the shrinkage is 
due to normal ageing, because not all AD patients exhibit shrinkage. There is neural loss in 
the cortex, hippocampus, amygdala, basal forebrain, locus coeruleus, raphe nuclei and 
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nucleus basalis of Meynert. The classic pathological symptoms of AD are (1) neurofibrillary 
tangles, (2) senile plaques, (3) granulovacuolar degeneration and (4) Hirano bodies. There 
are abnormal amyloid protein deposits in the demented individual`s brain (Muller-Hill and 
Beyreuther, 1989). Neurofibrillary tangles are straight or paired helical filaments that collect 
intracellular and are made up of special proteins (tau-protein). Tangles normally consist of 
a pair of helical filaments found in the cytoplasm of cortical and hippocampal pyramidal 
cells (Gallo and Anderton, 1989) and the amyloid β-protein is responsible for the formation 
of the senile plaques (Anderton, 1987). Temporal, parietal and frontal areas are specially 
affected by tangles. The tangles do not appear with normal ageing, although they are found 
in other dementias. Senile plaques are spherical and are made up of glia and abnormal nerve 
cell processes; these surround the extracellular amyloid proteins (usually β-amyloid). Senile 
plaques in the cortex are more pronounced in AD patients than in age-matched controls and 
some patients exhibit tangles but not plaques. Granulovascular degeneration occurs 
primarily in the hippocampus and, as the name suggests, results in neuronal tissue becoming 
full of holes. Finally, Hirano bodies are rod-shaped material that intrudes on neurons. The 
lesions neuropathological features appear most commonly in the hippocampus and 
entorhinal cortex in the early stages of the disease, later extending to the frontal, temporal 
and parietal lobes. Hippocampal and entorhinal abnormalities have been found to correlate 
with the severity of episodic memory impairment in the disease (Rémy et al., 2005). 
 
There is evidence of metabolism reduction in frontal, parietal and temporal regions and 
areas of metabolic reduction tend to be positively correlated with neuronal degeneration 
(Haxby et al., 1994).  
 
A loss of synapses in the AD brain has also been observed in certain pathways, which 
appears to correlate with the loss in intellectual function, these including cortical 
acetylcholine, acetylcholinetransferase and nicotinic receptors (Terry et al., 1991). 
 
In the mid-1970s, it was found that a loss of up to 70% of choline acetyltransferase, the 
cholinergic marker enzyme that synthesizes acetylcholine, occurs in the temporal and 
parietal cortices of these patients. This acetylcholine synthesis impairment is correlated 
with the severity of the dementia, and the loss of choline acetyltransferase is correlated with 
the number of senile plaques and the degree of dementia (Perry et al., 1999). In addition to 
the cholinergic system other neurotransmitter system has been implicated in AD, for 
example, serotonin and noradrenaline neurons markers have been found to be reduced in 
the cortex (Mann et al., 1982), a reduction possibility due to the loss of projections from 
the dorsal raphe and locus coeruleus to the cortex. Reductions in the concentration of 
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cortical noradrenaline have been found in a large number of other studies especially in the 
cingulate gyrus (e.g. Gottfries, 1990; Cross et al., 1984). 
 
 
1.3 Dementia and Autonomic function 
 
Autonomic dysfunction may result from primary modifications of the autonomic nervous 
system or be secondary to a wide range of diseases that cause severe morbidity and 
mortality. The autonomic nervous system, as a whole, is organized as a reflex arc being the 
sympathetic and the parasympathetic systems the motor portion of this reflex arc that also 
includes integrative centers located in the central nervous system (the central autonomic 
network) to which sensory information is conveyed from peripheral sensors located in 
specific reflexogenic areas. Stimulation of different parts of the cerebral cortex and the 
limbic system, which are relay stations of the central autonomic network, also produces 
autonomic effects and the higher centers of the brain can abnormally influence the activities 
of the autonomic nervous system and induce disease such as cardiac palpitations 
(arrhythmias) and even myocardial infarction. The evaluation of the autonomic 
performance and influence upon peripheral functions is performed through standard 
autonomic manoeuvres which are conceived to provoke the system and evaluate its 
dynamicity in terms of presence or absence of response, duration and magnitude.  
Usually, due to the nature of the recording devices, most maneuvers target the cardiovascular 
system and are non-invasive in nature. To avoid stimuli interference on ANS responses, 
autonomic evaluation should be performed in a dedicated laboratory with control of 
temperature, humidity, noise and environmental light by experienced technicians and 
under medical supervision.  
Patients undergoing autonomic evaluation should not consume food or tobacco, at least four 
hours before testing, and alcohol, at least 12 hours, before the evaluation, which should be 
performed during the morning. Medications, particularly those that directly affect the 
autonomic nervous system should be discontinued according to the drugs’ half-life and the 
patient’s condition. Due to the high data variability, both intra and inter-individuals, normal 
values are set by each laboratory and should be grouped by gender, age and decade of life 
(Low and Benarroch, 2008; Mathias and Bannister, 2012; Laranjo et al, 2017). The 
evaluation and data analysis protocols should also be appropriate to the study. Heart rate 
response to deep breathing, blood pressure and heart rate changes upon Valsalva 
manoeuvre and active standing are classical autonomic tests (Ducla-Soares et al, 2007; 
Xavier et al, 2008; Low and Benarroch, 2008; Mathias and Bannister, 2012). The gain or 
sensitivity of the baroreflex (BRS) as well as its efficacy are measures of the baroreceptor 
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function which is one of the main mechanisms regulating blood pressure in each moment. 
BRS can be assessed under dynamic or steady-state conditions by various methods 
correlating blood pressure spontaneous fluctuations with consecutive heart rate changes. 
The sequential method is one of those methods and searches for blood pressure and RR ramps (Di 
Rienzo et al, 1983). A ramp i s  defined as a variation of, at least, 1 mmHg and 4 ms 
between adjacent values of blood pressure and RR, respectively. This concept can only be 
applied to three or more cardiac cycles varying monotonically, either increasing or 
decreasing. When a BP ramp occurs at the same time as an RR ramp, a BRS event is 
identified. The baroreflex effectiveness index (BEI) is the ratio between the total number of 
BRS events and total number of pressure ramps, increasing or decreasing, for a given period. 
BEI is an indicator of the effectiveness of baroreceptor-mediated cardiac regulation 
(DiRienzo et al, 1983; Laranjo et al, 2017). Signal processing can be applied to autonomic 
evaluation in the time, frequency and time-scale domains can identify different pathological 
response profiles, such as delays in adaptive responses to provocative maneuvers, 
dyssynergia between BP and HR responses, and/or exaggerated responses such as 
orthostatic hypotension, postural orthostatic tachycardia and syncope.  
 
In particular, fast Fourier transform (FFT) has been widely used (Pagani et al, 1986; Laranjo 
et al 2017). By decomposing the signals it achieves a range of low (LF; 0.04-0.15 Hz) and high 
frequencies (HF; 0.15-0.4 Hz) linked to sympathetic and parasympathetic nervous systems 
(Task Force ESC, 1996) FFT analysis requires a stationary signal and a long period of data 
collection, of at least 5 min and it cannot locate and follow changes in a frequency over time 
which are overcome a wavelet-based. Wavelet coherence can also be used to analyze the 
degree of autonomic remodeling in patients under specific therapeutic schemes. 
 
Prefrontal cortex activity has been associated with changes to heart rate variability (HRV) 
a measure of autonomic nervous functioning, via mediation of the cortico-subcortical 
pathways that regulate the parasympathetic and sympathetic branches of the autonomic 
nervous system (ECS, 1996). Changes in HRV due to altered prefrontal suggests that 
prefrontal hyperactivity increases parasympathetic tone and decreases contributions from 
the sympathetic nervous system (Thaye and Sternberg, 2006). Alteration of prefrontal 
cortex activity has been independently demonstrated to modulate HRV using both non-
invasive brain stimulation (Brunoni AR et al., 2013) and cognitive tasks reliant on prefrontal 
functioning (Laborde et al., 2015). Therefore, activation of the prefrontal cortex results in 
change to HRV (Lane et al., 2001; Napadow et al. 2008) which can be thought of as a measure 
of the aggregate effect of activity in a complex brain network, regulated top-down by the 
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prefrontal cortex. According to this model, hyper-activation of the prefrontal cortex inhibits 
the sympathoexcitatory circuit of the amygdala, which is known to have outputs relevant to 
autonomic regulation (Thayer and Sternberg, 2006). This in turn reduces sympathetic 
activity and parasympathetic suppression, culminating in a reduction in heart rate. 
 
In this context it has been found that autonomic failure of patients with neurodegenerative 
disorders may occur (Borson et al., 1992; Chu et al., 1994; Algotsson et al., 1995; Kaufmann 
et al., 2003). The autonomic nervous system together with the endocrine and the immune 
systems contributes to the maintenance of homeostasis by function controlling and its 
dysfunction may result from primary neurological diseases (Ducla-Soares et al., 1993; 
Mathias & Polinsky, 1999; Goldstein et al., 2002; Kaufmann & Biaggioni, 2003). In these 
cases Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and 
Alzheimer's disease are the most prevalent related neurodegenerative disorders 
(Kaufmann et al., 2003). However, the most severe dysautonomia are usually related to 
traumatic or vascular cerebral pathology (e.g. traumatic brain-injury or cerebrovascular 
infarction) as the targeting of areas of the central autonomic network is more effective. 
 
In a study conducted by Ballard (1998) there was a prevalence of autonomic system changes 
in 57% of patients with AD (eg.: orthostatic hypotension, vasovagal syncope and carotid 
sinus hypersensitivity). Other studies were consistent in demonstrating autonomic 
dysfunction in these patients (Aharon-Peretz et al. 1992), such as the exacerbation of the 
sympathetic system with relative depression of the parasympathetic system (Vitiello et al., 
1993), blood pressure response dysfunction to the standing posture test and decreased 
parasympathetic function at rest and during deep breathing (Wang et al., 1994; Ferini- 
Strambi et al., 1997). Another study demonstrated a greater decrease in blood pressure 
during orthostatic position in AD patients compared to controls (Allan et al. 2005; 2007). It 
also observed the sympathetic involvement in alpha-synucleinopathies including dementia 
with Lewy bodies. In those patients, MIBG uptake was demonstrated to be reduced 
(Miyamoto et al, 2008) as well as the plasma norepinephrine concentrations in supine and 
standing positions. 
 
The dysfunction of cortical systems involved in memory processes are the most investigated 
in AD, however, a possible mechanism for the neurobiological substrates of autonomic 
deregulation can also be cortical area dysfunction. At this level again, neuroanatomical, 
lesion and electrophysiological studies evidenced the role of the prefrontal cortex 
ventromedial and orbitofrontal area and anterior insula (Neafsey, 1990; Cechetto and 
Saper, 1990), projecting directly to important subcortical autonomic centers (e.g. amygdala, 
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thalamus, hypothalamus, cerebellum and brainstem). The hyper-excitability in these areas 
can cause lethal arrhythmias and myocardial infarction (Oppenheimer et al., 1992). These 
patients, when faced with the need to respond to demanding cognitive challenges (Borson 
et al., 1992) or emotionally intense stimuli (Chu et al. 1994) triggered dysautonomia due to 
the failure to coordinate between higher mental activity and somatic response which, at the 
level of autonomic dysfunction, represents an important pathogenesis (Aharon-Peretz et al., 
1992; Algotsson et al., 1995). 
 
These observations have led to the understanding that healthy physiologic function is a 
result of continuous, dynamic interactions between multiple neural, hormonal, and 
mechanical control systems at both local and central levels. The interactions between 
autonomic neural activity, BP, and respiratory control systems produce short-term rhythms 
in HRV measurements (Hirsch and Bishop 1981, 1996; McCraty et al., 2009). The most 
common form for observing these changes is the heart rate tachogram, a plot of a sequence 
of time intervals between R waves. Efferent sympathetic and parasympathetic activity is 
integrated in and with the activity occurring in the heart’s intrinsic nervous system, 
including the afferent signals occurring from the mechanosensitive and chemosensory 
neurons, all of which contribute to beat-to-beat changes. HRV is thus considered a measure 
of neurocardiac function that reflects heart-brain interactions and ANS dynamics (Mateo et 
al., 2011). HRV can also be an indicator of psychological resiliency and behavioral flexibility, 
reflecting the individual’s capacity to adapt effectively to changing social or environmental 
demands (Beauchaine, 2001; Berntson et al., 2008). Several studies have shown an 
association between higher levels of resting HRV and performance on cognitive performance 
tasks requiring the use of executive functions (Thayer et al., 2009) can be increased in order 
to produce improvements in cognitive function as well as a wide range of clinical outcomes, 
including reduced health care costs (Lehrer et al., 2003; 2008; McCraty et al., 2003; Bedell 
and Kaszkin-Bettag, 2010; Alabdulgader, 2012). 
 
Dementia seems to develop differently in the brain of afrodescendent patients than in 
whites. Afrodescendent people apparently are more likely to suffer different types of brain 
changes as microstrokes, Lewy bodies development and blood vessel disease, that will also 
contribute to dementia (Barnes et al., 2015). These findings suggest that afrodescendent 
patients might have different risk factors for dementia which may be related to specific 
genetic differences and to the high prevalence, in this population, of heart disease, high 
blood pressure and type 2 diabetes (Barnes et al., 2015). The later are a group of risk factors 
for brain strokes and run with autonomic dysfunction since the earlier stages. Thus, learning 
the differences between afrodescendent and white dementia patients and their causes will 
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be critically important to find more specific therapeutics for dementia which could also 
address the expression of the disease among ethnicities and improve the support to these 
patients, their families and caregivers. 
 
 
1.4. The Recruitment of vulnerable populations into research 
 
Although it is implied that minorities are adequately represented in clinical trials and other 
investigational studies, they still have low inclusion rates in health research compared to 
non-minority groups. Certain social groups continue to be excluded from social research, 
being as an example, women, sexual minorities and ethnic minorities, among others 
(Cundiff, 2012). In the last decade some authors have been dedicated to review the situation 
of these minority populations (UyBico,Pavel & Cross, 2007), having identified several 
specific barriers to the recruitment of minorities for research studies which can be grouped 
essentially into three types: institutional, from the researcher and from the patient. The 
former is mainly related to administrative and time constraints regarding the research 
sponsor while at the researcher level are included multicultural differences, lack of 
knowledge of the research project and methods and non-acceptance of the project 
leadership.  
Barriers at the patient level include distrust of research, lack of confidentiality, insecurity, 
poor access to medical care, lack of knowledge, language comprehension and cultural 
differences (UyBico, Pavel & Cross, 2007). The researcher access to this social excluded 
groups can fail because some classical sampling methods are ineffective or inappropriate 
regarding group’s social or physical location, vulnerability, or otherwise hidden nature 
(Ellard-Gray, et al. 2015). When a population is difficult to access, researchers generally 
describe them as hard to reach populations because of their physical or social locations (e.g., 
remote geographical location, social elites or social culture issue), but they may also be hard 
to reach because they are vulnerable (i.e., disenfranchised, subject to discrimination or 
stigma) or hidden (i.e., populations with no defined limits or sampling parameters) 
(Shaghaghi, Bhopal & Sheik, 2011; Sydor 2013). 
 
Despite these barriers, minorities appear to be willing to participate in research studies if 
given opportunities to do so. One of the possible recommendations regarding this problem 
is starting from early stages of study design to dissemination of study results. In fact, as the 
possibility of minority recruitment has increased, research promoters' interest in planning 
minority recruitment interventions has increased. Suggested approaches include recruiting 
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through partnerships with churches and community organizations, recruiting at community 
clinic settings and providing logistical assistance or financial encouragement as well as 
awareness-raising campaigns that promote disease awareness and behaviour change 
because recruitment is one of the most significant challenges in conducting research with 
ethnic minority populations, establishing relationships with organizations that serve ethnic 
minority communities can facilitate recruitment (Alvarez et al., 2006) 
 
For instance, in Portugal, the Alzheimer Portugal Association; Alzheimer Acores Association 
and Alzheimer Pinhal Litoral Association are three non-profit organizations dedicated to 
support people with Alzheimer disease and/or any other forms of dementia and also seek 
to study and increase the existent knowledge about the disease. This working organizations 
have been promoted health communication and media strategic communication as the 
driving forces to promote health literacy matching the carers’ needs (Nunes, 2017). In the 
face of dementia, diagnosed or not, the lack of information may be the reason for resorting to 
a health service, as an express or indirectly need of the family. Many family members know 
that dementia causes cognitive limitations, but they do not understand executive deficits, 
the meaning of apraxia, or delusional symptomatology. Others are blamed for the outbreak 
(e.g., after a change of address, which may have coincided with the onset of symptoms, at 
most, by the nonspecific role of stress in the diminished brain reserve). These situations 
often produce distress and inadequate responses in family members, triggering destructive 
interactions with the sick person (Gonçalves-Pereira & Sampaio, 2011). 
 
For these psychosocial and cultural reasons, in Portugal, it seems to remain difficult certain 
groups of patients access to the adequate and timely health care services or, consequently, 
to the possibility of informed and motivated participation in clinical and scientific research 
studies, such as controlled clinical trials or other prospective experimental human-models. 
 
However, in the last year 2018, a strategic dementia health plan was approved and published 
by the Portuguese Ministry of Health (published in Diário da República n.º 116/2018, Series 
II of 2018-06-19 by order n.º 5988/2018). This national plan guiding document may help 
to contribute in the future to the recruitment of vulnerable populations dementia patients 
of a specific ethnicity or race, because defines in Portugal “the principles to be followed by 
the care of people with dementia, the criteria to be used for preventive intervention, the 
measures to be taken with regard to early detection, the measures for access to medical 
diagnosis and comprehensive diagnosis, and the therapeutic responses at the three levels of 
health care, clarifying a care path for people with dementia, based on the principles of ethics, 
proximity, accessibility, equity and continuity ”. This strategic plan focuses on issues such as 
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global economic impact; the stigma; promotion of diagnosis; early intervention; the needs 
of families and informal caregivers and long-term care, based on best practices developed 
in reference countries and the World Health Organization (WHO) guidelines; OECD and 
Alzheimer's Disease International. On this document, greater emphasis has been placed on 
greater sharing of responsibilities between public, social and solidarity, private and 
academic institutions and greater public awareness, particularly of decision-makers, of the 
problem of dementia. Although awareness has been steadily increasing, it remains low in 
the face of the scale of the problem and there is still a high lack of knowledge about the 
theme, regarding the signs and symptoms of dementia, the diagnostic and intervention 
process, or the existing responses in the community. Because false beliefs and 
unconstructive attitudes associated with dementia persist, negatively affecting the quality 
of life of people in their teeth and families. Improving awareness and education, developing 
possibilities for early diagnosis and treatment are among the priority areas identified in the 
generality of this plan. It is recognized that stigma associated with dementia and a better 
understanding of this issue can help to reduce discrimination and social exclusion by 
promoting timely access to diagnosis and health care. 
 
And finally, it is encouraged the creation of innovative technological and research projects 
with value to the different stakeholders, looking for integrated solutions for the definition 
of policies and services, and improving the well-being of these patients and their supportive 
networks (family, caregivers), neighborhood, service providers, etc.). 
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2. AIM OF THE PRESENT WORK 
 
Central autonomic network stations such as the hypothalamus, the amygdala, the insula and 
locus coeruleus are affected in the early stages of dementia. Body systems dysfunction such 
as cardiac, urinary or thermoregulatory have been already reported in dementia 
investigations but studies on the integrity of the overall autonomic function in dementia has 
been limited and needed detailed exploration, in particular in cohorts of ethnic patients. 
Therefore, the overall purpose of the present Master Thesis is to investigate autonomic 







3.1. Ethics Statement 
The study complied with the Declaration of Helsinki and was submitted to Faculty of 
Medicine/CAML Ethical Committee, ratified by Fernando Fonseca Hospital Ethical 
Committee and performed under informed consent. 
 
 
3.2. Increasing project awareness to facilitate patient’s recruitment 
Following the approval of this project by the Ethics and Clinical Research Committees of the 
Lisbon Medical School of the University of Lisbon and the Fernando Fonseca Hospital (HFF), 
this work was presented to the coordinators of the clinical and health institutions under 
HFF's geography influence area, to disclose it and to raise resources for identifying 
participants based on inclusion and exclusion criteria’s. For that purpose communication 
materials have been developed and oral presentations of the project have been done at CERCITOP, 
CRL and to Clinical and Scientific Commission of Sintra and Amadora ACeS who 
disseminated the project and its purpose among the various primary care centers of both 
municipalities. The study was also submitted to the ARS-LVT Ethics and Scientific 
Committee. This referral network took about a year to be established between 2016 and 
2017, based on our belief on the health gains that this academic research work could bring 
to the clinical practice and to treatment of a vulnerable minority of dementia patients, users 






3.3 Study Population 
Non-Caucasian afrodescendent subjects, of both sexes (n=22), aged ≥50 years, diagnosed 
with mild dementia defined in accordance to DSM criteria were enrolled. A group of 
Caucasian subjects with the same diagnostic criteria of mild dementia (n=7) and a control 
group of multi-ethnic subjects without cognitive impairment (n=12) matching age and sex 
were also included in the study. 
 
The participants were recruited and evaluated between February 2018 and May 2019 at the 
HFF’s Neurology Department in collaboration with CERCITOP, CRL upon their first medical 
appointment due to complaints of cognitive decline. All patients were subjected to history 
taking, physical examination and an anamnesis of dementia. Drug history, hypertension, 
dyslipidemia, educational years, occupation and birthplace also recorded. Participants with 
atrial fibrillation ablation or implantation of a pacemaker, diabetes, chronic obstructive 
pulmonary disease, orthostatic hypotension, reflex syncope, cardiac arrhythmias, heart 
failure, those who had undergone cardiac surgery, those who were taken beta-blockers or 
several psychotropic medications such as tricyclic antidepressants, selective serotonin-
epinephrine reuptake inhibitors, atypical antidepressants, antipsychotics and cholinesterase 
inhibitors or have other significant medical causes of dementia (hypothyroidism, chronic 
sub-dural hematoma, asthma, multiple sclerosis) were excluded from this study. Due to the 
age of the studied population some medications were allowed and they included diuretics, 
peripheral acting calcium channel blockers, angiotensin converting enzyme inhibitors, 
angiotensin II receptor blockers, serotonin reuptake inhibitors and benzodiazepines. 
 
After the first medical appointment, the identification of possible patients to be included was 
made but only after confirmation of mild dementia diagnosis based on neurological 
evaluation and neuropsychological assessment through cognitive and functional tests. If the 
patient met the study inclusion criteria, then, after a study detailed explanation, which 
included its purposes and the protocols to be performed, the patient was left free to decide 
to participate or not in it. If a positive decision was made, then an inform consent document 
was signed and the patient enrolled (Figure 1). Of the initial group of identified patients only 












3.4. Clinical and Neuropsychological assessment 
All subjects underwent a detailed clinical evaluation. Socio demographics (age, gender, 
education), lifestyle habits (smoking, coffee and alcohol consumption, physical activity), 
therapeutics, routine blood tests panel mainly glucose and lipids and co-morbidities were 
taken. Body mass index (BMI) was calculated as weight/height (Kg/m2); alcohol 
consumption was expressed as alcohol units/day (1 unit=10g alcohol) based on average 
alcohol content by volume of the drinks consumed (Kerr and Stockwell, 2012). Clinical 
diagnosis of mild dementia was confirmed by neurological and neuropsychological 
assessment and based on DSM classifications. The neuropsychological evaluation included 
the application of the Mini-Mental State Examination [MMSE; score between 22-26 
(application time: 5min)], the Clinical Dementia Rating [CDR; score between 0.5-1 
(application time: 30 min)] and the Questionnaire Subjective Memory complaints [QSM; 
score from 0 to 21 (application time: 5 min)]. 
 
 
3.5 Experimental protocol 
All the autonomic tests were performed in a dedicated laboratory, in quiet environment with 
controlled environmental conditions (humidity, temperature, light and noise), during the 
afternoon period between 4pm and 8pm, to minimize the effect of circadian changes in 
autonomic evaluation. Patients were instructed to have a light lunch and to refrain alcohol, 




3.5.1. Autonomic evaluation 
Upon arrival to the autonomic lab, patients were instructed to sit comfortably, to remain 
silent while breathing spontaneously. Beat-to-beat RR-intervals and arterial blood pressure 
were continuously monitored using a Task Force Monitor (CNSystems, Graz, Austria) during 
the entire testing. After an initial period of stabilization of 15 minutes, the following tests 
were sequentially performed leaving between them a period of stabilization of 10 minutes 
(Figure 2): 
 
1st Deep metronomic breathing test (DB): the subject was instructed to 
breathe deeply at a rate of 6 breaths for a period of 1 min (alternating air 
inhalation and exhalation for 6 times) guided by a metronome and a 
visual sign. 
 
2nd Valsalva manoeuvre (VM): subjects deep breathed and immediately 
blow into a tube connected to a sphygmomanometer, holding it at a 
pressure of 40 mmHg for 15 seconds. After this period, subjects 
remained seated in a resting position for 2 minutes breathing normally. 
 
3rd Hand grip (HG): after a third resting period of 10 minutes to 
guarantee a stable condition, the subject performed a maximum grip 
with his dominant hand and the maximum capacity was noted. Then 
after five minutes, a grip of 30% of his maximum capacity was hold for 5 
min after which it was released. The subject was instructed to breath 
normally during the grip in order to avoid sustained inspiration that 
would mimic a VM. 
 
When a manoeuvre was not correctly performed, a period of 5 minutes was allowed to 
elapse and a new attempt was made. 






3.6 Data analysis 
 
3.6.1 Ewing Battery analysis 
Autonomic evaluation on the time domain was performed as follows: 
 
 
- DB: The expiratory-inspiratory ratio (E:I ratio), which is the ratio 
of the longest RR interval during expiration and the shortest RR 
interval during inspiration from 6 cycles, was calculated; 
 
- VM: The Valsalva ratio derived from the longest RR interval in 
phase IV divided by the shortest RR interval in phase II was 
calculated as well as the changes on blood pressure during phase 
II; 
 
- HG: The result of this manoeuvre is presented as the difference 
between the highest diastolic pressure during the examination 
and the average diastolic pressure at rest. 
 
 
3.6.2 Cardiovascular variability 
Cardiovascular variability analysis was performed in the time -scale domain through wavelet 
analysis using an in-house computational interface FisioSinal. The application of wavelets 
Db12 to autonomic evaluation allows a dynamic assessment of autonomic function with 
physiological significance over short periods of time with a minimum duration of 20s. After 
processing, the resulting spectral frequencies are: 1) low frequency power (LF; 0.04- 015Hz), 
high frequency power (HF;.15-0.4Hz) expressed in absolute units (mmHg2 and ms2, 
respectively).  
The overall autonomic power was calculated through the relation LF/HF (mmHg2/ms2). 
For the assessment of overall autonomic tone, the analysis of each cardiovascular 
parameter, systolic blood pressure and RR intervals, was made as follows in the period of 5 
minutes immediately before the deep breathing test through the evaluation of heart rate and 
systolic blood pressure variability. Deep breathing, Valsalva manoeuvre and hand grip were 
evaluated through the Ewing analysis as the irregularity of the signals did not allow the 







3.6.3 Baroreflex Gain and Effectiveness  
Baroreflex sensitivity was calculated using the sequence method as stated elsewhere (Di 
Rienzo et al., 2001; Iacoviello et al., 2011). In brief, this estimation is based on the analysis of 
beat-to-beat series of systolic blood pressure scanned in order to identify ramps of 3 or more 
consecutive heart beats with a progressive increase (up-ramp) or decrease (down- ramp), 
of at least 1mmHg, regardless of the possible occurrence of concomitant RR interval changes. 
The algorithm identifies spontaneous sequences, defined as systolic blood pressure ramps 
followed by concomitant and concordant RR intervals variations of 5 milliseconds coupled 
with 0-, 1-, and 2-beat lags, with each sequence being included only once. For each sequence, 
the slope of the linear interrelationship between systolic blood pressure and the following 
RR intervals values was calculated and was considered reliable when the correlation 
coefficient was greater than 0.80. For each period of analysis, the baroreflex effectiveness 
index is defined as the ratio between the total number of baroreflex sensitivity sequences 
detected and the total number of systolic blood pressure ramp-like changes in blood 
pressure, regardless of whether the later are followed by a change in RR-interval or not 20. 
The higher the effectiveness value, the more systolic blood pressure ramp changes are 
followed by a change in RR-interval. 
 
 
3.7 Statistical analysis 
Continuous variables were expressed as mean and standard error and plotted as the 
composite of the mean values of all subjects, unless otherwise specified. Categorical 
variables are given as frequencies and percentage of patients and for neuropsychological 
evaluation data are expressed as mean and standard deviation. Normality distribution of the 
continuous variables were analyzed with the Kolmogorov-Smirnov test (Lilliefors’ 
correction) and Levene's test for assessment of homogeneity of variance. Data from different 
subjects - patients and controls groups - were represented along time. Student's T test was 
used to assess all paired data in the same group. Comparison between groups was made 
using a "repeated measures" analysis of variance (ANOVA) with one "within" factor (the 
consecutive periods of analysis) and one "between" factor (patients vs controls) with 
Bonferroni’s correction. A value of p<0.05 was considered statistically significant. Data were 













4.1 Demographics and Neuropsychological assessment: 
 
Many of patients were geriatric and polymorbid, which is a regular finding in dementia 
patients. Nevertheless, patients were divided into three groups according to their age 
distribution and ethnicity: AfD [50-70] years, AfD >70years and CA>70years. The CA>70 
years with mild dementia was used to compare results regarding ethnicity in those patients aged 
>70 years. A group of afrodescendent subjects with [50-70] years without dementia was used 
as control of the AfD [50-70] group. Results show no significant differences between AfD [50-
70] years and the control group [50-70] years and between AfD >70 years and CA>70 years 
in most of the factors that may potentially affect the autonomic evaluation as seen in Tables 





Parameter Control group AfD patients 
 (n=12) (n=15) 
Age (years) 64±2.6 58.6±5,8 
Gender (%male) 53 33 
Education (years) 10.4 7.5±4,0 
BMI (Kg/m2) 30.9±1.8 27.1±1.7 
Resting sBP (mmHg) 138.2±4.7 133.0±5.7 
Resting dBP (mmHg) 81.1±3.6 83.0±3.5 
Resting Heart rate (beats/min) 68±3.4 77.8±4.2 
Number of medications 1.9±1.1 5.9±2.1 
MMSE score -- 24,6±1,5 
CDR score -- 0,7±0,3 
QSM score -- 10,5±5,3 
Table 1. Baseline demographic data for AfD mild dementia and control groups: subjects aged 
[50- 70] years. Continuous data are expressed in mean±SEM; categorical variables are expressed 
as %. Neuropsychological evaluation is expressed as mean±SD. If applicable, significant results 










Parameter AfD patients CA patients 
 (n=7) (n=7) 
Age (years) 79±5,7 76,6±5,3 
Gender (%male) 14 14 
Education (years) 4,4±2,6 4,4±2,1 
BMI (Kg/m2) 24.3±1.5 24.6±1.4 
Resting sBP (mmHg) 126±8.9 124±8.2 
Resting dBP (mmHg) 83±3.5 74±4.4 
Resting Heart rate (beats/min) 66±3.5 70±5.4 
MMSE score 23,4±1,8 24,6±1,6 
CDR score 0,9±0,2 0,6±0,2 
QSM score 5,7±2,6          8,1±5,3 
Table 2. Baseline demographic data for AfD and CA mild dementia groups: patients aged >70 
years. Continuous data are expressed in mean±SEM; categorical variables are expressed as %. 
Neuropsychological evaluation is expressed as mean±SD. If applicable, significant results 






For the neuropsychological evaluation, patients were also divided into two groups according 
to their age distribution: [50-70] years and >70 years among the afrodescendent and 
caucasian subjects, respectively. The results of such evaluation are depicted in accordance 
with the typology of the patient’s groups and characteristics such as age and education (see 
next Tables 3, 6 and 9) and cognitive subdomains (see next Tables 4, 7 and 10 for MMSE and 














Group I: Afrodescendents [50-70] years (n =15) 
 
Neuropsychological tests; Age & Education 
 
N   Minimum Maximum            Mean          Std deviation 
MMSE 15 22,00 26,00 24,6000 1,45406 
CDR 15 ,50 1,00 ,7000 ,25355 
QSM 15 ,00 20,00 10,4667 5,28970 
Age 15 50,00 66,00 58,6000 5,79162 
Education 15 ,00 17,00 7,4667 3,96172 
Valid N (listwise) 15     
Table 3. Neuropsychological tests; Age & Education in the [50-70] years group of 
Afrodescendent subjects. Data expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 15 AfD patients present a range of ages from 
50 years (minimum) to 66 years (maximum) with a total age weighted average of 58,6±5,8; an 
educational level ranging from 0 years (minimum: illiterate) to 17 years (maximum) with a 
mean of 7,5±4,0; a variation in the MMSE score of 22/30 (minimum) to 26/30 (maximum) with 
a total weighted average of 24,6±1,5; a variation in the CDR score of 0,5/3 (minimum) to 1/3 
(maximum) with a total weighted average of 0,7±0,3 and a variation in the QSM score from 




MMSE cognitive subdomains 
 
N Minimum   Maximum Mean   Std. Deviation 
Orientation 15 6,00 10,00 8,6667 1,17514 
Retention 15 3,00 3,00 3,0000 ,00000 
Atent_Calcul 15 1,00 5,00 3,6000 1,54919 
Recall 15 ,00 3,00 1,3333 ,89974 
Language 15 6,00 8,00 7,5333 ,74322 
Const_skill 15 ,00 1,00 ,4667 ,51640 
Valid N (listwise) 15     
Table 4. MMSE cognitive subdomains scores in the [50-70] years group of Afrodescendent 
subjects. Data expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 15 afrodescendent subjects presents in 
the MMSE subdomains scores: a range of Orientation from 6/10 (minimum) to 10/10 (maxi- 
mum) with a weighted average score of 8,6±1,2; a range of mnesic Retention from 3/3 
(minimum) to 3/3 (maximum) with a mean score of 3,0; a range of Attention_Calculation from 
1/5 (minimum) to 5/5 (maximum) with a weighted average score of 3,6±1,5; a range of mnesic 
Recall from 0/3 (minimum) to 3/3 (maximum) with a weighted average score of 1,3±0,9; a 
range of Language competencies from 6/8 (minimum) to 8/8 (maximum) with a weighted 
average score of 7,5±0,7 and a range of Constructive_skills competencies from 0/1 (minimum) 






CDR cognitive subdomains 
 
N   Minimum Maximum Mean Std. Deviation 
Memory 15 ,50 2,00 ,9000 ,38730 
Orientation 15 ,00 1,00 ,6667 ,36187 
Judgment 15 ,00 1,00 ,5000 ,32733 
Common_affairs 15 ,00 1,00 ,6667 ,30861 
Home_Hobbies 15 ,00 1,00 ,4667 ,39940 
Personal_care 15 ,00 1,00 ,2667 ,45774 
Valid N (listwise) 15     
Table 5. CDR cognitive subdomains scores in the [50-70] years group of Afrodescendent 
subjects. Data expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 15 afrodescendent subjects presents in the 
CDR subdomains scores: a range of Memory from 0,5/3 (minimum) to 2/3 (maximum) with a 
mean score of 0,9±0,4; a range of Orientation from 0/3 (minimum) to 1/3 (maximum) with a 
mean score of 0,7±0,4; a range of Judgement (and Problem solving) from 0/3 (minimum) to 1/3 
(maximum) with a mean score of 0,5 0,3; a range of Community_affairs abilities from 0/3 
(minimum) to 1/3 (maximum) with a mean score of 0,7±0,3; a range of Home_Hobbies activities 
competencies from 0/3 (minimum) to 1/3 (maximum) with a mean score of 0,5±0,4 and lastly 
a range of Personal_care autonomy from 0/3 (minimum) to 1/3 (maximum) with a mean score 
of 0,3±0,5.  
 
 
Group II: >70 years afrodescendent subjects (n =7): 
 
 
Neuropsychological tests; Age & Education 
 
N   Minimum      Maximum        Mean          Std. Deviation 
MMSE 7 22,00 26,00 23,4286 1,81265 
CDR 7 ,50 1,00 ,8571 ,24398 
QSM 7 3,00 10,00 5,7143 2,62769 
Age 7 71,00 86,00 79,0000 5,68624 
Education 7 ,00 9,00 4,4286 2,63674 
Valid N (listwise) 7     
Table 6. Neuropsychological tests; Age & Education in the >70 years group of Afrodescendent 
subjects. Data expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 7 afrodescendent subjects presents: a range 
of ages from 71 years (minimum) to 86 years (maximum) with a total age weighted average of 
79±5,7; an educational level ranging from 0 years (minimum: illiterate) to 9 years (maximum) 
with a mean of 4,4±2,6; a variation in the MMSE score of 22/30 (minimum) to 26/30 (maximum) 
with a total weighted average of 23,4±1,8; a variation in the CDR score of 0,5/3 (minimum) to 
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1/3 (maximum) with a total weighted average of 0,9±0,2 and a variation in the QSM score of 
3/21 (minimum) to 10/21 (maximum) with a total weighted average of 5,7±2,6.  
 
 
MMSE cognitive subdomains 
 
N Minimum   Maximum Mean Std. Deviation 
Orientation 7 8,00 10,00 9,2857 ,75593 
Retention 7 3,00 3,00 3,0000 ,00000 
Atention_Calc 7 1,00 5,00 2,4286 1,61835 
Recall 7 ,00 2,00 1,0000 ,57735 
Language 7 6,00 8,00 7,4286 ,97590 
Contruct_skill 7 ,00 1,00 ,2857 ,48795 
Valid N (listwise) 7     
Table 7. MMSE cognitive subdomains scores in the >70 years group of Afrodescendent subjects. 
Data expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 7 afrodescendent subjects presents in the 
MMSE subdomains scores: a range of Orientation from 8/10 (minimum) to 10/10 (maximum) 
with a weighted average score of 9,2±0,8; a range of mnesic Retention from 3/3 (minimum) to 
3/3 (maximum) with also total weighted average score of 3,00; a range of Attention_Calculation 
from 1/5 (minimum) to 5/5 (maximum) with a weighted average score of 2,4±1,6; a range of 
mnesic Recall from 0/3 (minimum) to 2/3 (maximum) with a weighted average score of 1,0±0,6; 
a range of Language competencies from 6/8 (minimum) to 8/8 (maximum) with a weighted 
average score of 7,4±1,0 and a range of Constructive_skills competencies from 0/1 (minimum) to 




CDR cognitive subdomains 
 
N Minimum   Maximum Mean Std. Deviation 
Memory 7 ,50 1,00 ,9286 ,18898 
Orientation 7 ,00 1,00 ,3571 ,37796 
Judgement 7 ,50 1,00 ,8571 ,24398 
Commun_affair 7 ,50 1,00 ,9286 ,18898 
Home_Hobbie 7 ,50 1,00 ,8571 ,24398 
Person_care 7 ,00 1,00 ,5714 ,53452 
Valid N (listwise) 7     
Table 8. CDR cognitive subdomains scores in the >70years group of Afrodescendent subjects. 
Data expressed as mean±SD.  
 
From the descriptive analysis of above the table, the 7 afrodescendent subjects presents in the 
CDR subdomains scores: a range of Memory from 0,5/3 (minimum) to 1/3 (maximum) with a 
mean score of 0,9±0,2; a range of Orientation from 0/3 (minimum) to 1/3 (maximum) with a 
mean score of 0,4±0,4; a range of Judgement (and Problem solving) from 0,5/3 (minimum) to 
 
54 
1/3 (maximum) with a mean score of 0,9±0,2; a range of Community_affairs abilities from 0,5/3 
(minimum) to 1/3 (maximum) with a mean score of 0,9 0,2; a range of Home_Hobbies 
activities competencies from 0,5/3 (minimum) to 1/3 (maximum) with a mean score of 
0,9±0,3 and lastly a range of Personal_care autonomy from 0/3 (minimum) to 1/3 (maximum) 
with a mean score of 0,6±0,5.  
 
 
Group II: >70 years caucasian subjects (n =7): 
 
 
Neuropsychological tests; Age & Education 
 
N Minimum       Maximum          Mean             Std. Deviation 
MMSE 7 22,00 26,00 24,5714 1,61835 
CDR 7 ,50 1,00 ,6429 ,24398 
QSM 7 1,00 15,00 8,1429 5,33631 
Age 7 71,00 82,00 76,5714 5,28700 
Education 7 3,00 9,00 4,4286 2,07020 
Valid N (listwise) 7     
Table 9. Neuropsychological tests; Age & Education in the >70 years group of Caucasian 
subjects. Data expressed as mean±SD.  
 
From the descriptive analysis of above table, the 7 caucasian subjects presents: a range of ages 
from 71 years (minimum) to 862 years (maximum) with a total age weighted average of 
76,6±5,3; an educational level ranging from 3 years (minimum) to 9 years (maximum) with a 
mean of 4,4±2,1; a variation in the MMSE score of 22/30 (minimum) to 26/30 (maximum) with a 
total weighted average of 24,6±1,6; a variation in the CDR score of 0,5/3 (minimum) to 1/3 
(maximum) with a total weighted average of 0,6±0,2 and a variation in the QSM score of 1/21 




MMSE cognitive subdomains 
 
        N         Minimum           Maximum     Mean Std.Deviation 
Orientation 7 5,00 10,00 8,5714 1,71825 
Retention 7 3,00 3,00 3,0000 ,00000 
Atention_Calcu 7 2,00 5,00 3,2857 1,11270 
Recall 7 ,00 3,00 1,2857 1,11270 
Language 7 8,00 8,00 8,0000 ,00000 
Const_skill 7 ,00 1,00 ,4286 ,53452 
Valid N (listwise) 7     
Table 10. MMSE cognitive subdomains scores in the >70 years group of Caucasian subjects. 
 
From the descriptive analysis of the above table, the 7 caucasian subjects presents in the MMSE 
subdomains scores: a range of Orientation from 5/10 (minimum) to 10/10 (maximum) with a 
weighted average score of 8,5±1,7; a range of mnesic Retention from 3/3 (minimum) to 3/3 
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(maximum) with also a total weighted average score of 3,00; a range of Attention_Calculation 
from 2/5 (minimum) to 5/5 (maximum) with a weighted average score of 3,2±1,1; a range of 
mnesic Recall from 0/3 (minimum) to 3/3 (maximum) with a weighted average score of 1,2±1,1; 
a range of Language competencies from 8/8 (minimum) to 8/8 (maximum) with also a weighted 
average score of 8,00 and a range of Constructive_skills competencies from 0/1 (minimum) to 




CDR cognitive subdomains 
 
N Minimum      Maximum     Mean      Std. Deviation 
Memory 7 ,50 1,00 ,9286 ,18898 
Orientation 7 ,50 1,00 ,7143 ,26726 
Judgement 7 ,00 1,00 ,5000 ,28868 
Commun_affairs 7 ,00 1,00 ,5000 ,40825 
Home_Hobbie 7 ,50 1,00 ,7143 ,26726 
Personal_care 7 ,00 1,00 ,1429 ,37796 
Valid N (listwise) 7     
Table 11. CDR cognitive subdomains scores in the >70 years group of Caucasian subjects. . Data 
expressed as mean±SD.  
 
From the descriptive analysis of the above table, the 7 caucasian subjects presents in the CDR 
subdomains scores: a range of Memory from 0,5/3 (minimum) to 1/3 (maximum) with a mean 
score of 0,9±0,2; a range of Orientation from 0,5/3 (minimum) to 1/3 (maximum) with a mean 
score of 0,7±0,3; a range of Judgement (and Problem solving) from 0,5/3 (minimum) to 1/3 
(maximum) with a mean score of 0,5±0,3; a range of Community_affairs abilities from 0/3 
(minimum) to 1/3 (maximum) with a mean score of 0,5±0,4; range of Home_Hobbies activities 
competencies from 0,5/3 (minimum) to 1/3 (maximum) with a mean score of 0,7±0,3 and lastly 




















Group I AfD 15 24,6±1,5 0,7±0,3 10,5±5,3 58,6±5,8 7,5±4,0 
Group II AfD 7 23,4±1,8 0,9±0,2 5,7±2,6 79±5,7 4,4±2,6 
Group II CA 7 24,6±1,6 0,6±0,2 8,1±5,3 76,6±5,3 4,4±2,1 
Table 12. Neuropsychological tests; Age & Education means scores between Patients-groups 
(Group I AfD: [50-70] years afrodescendent subjects; Group II AfD: >70 age afrodescendent 
subjects; Group II CA: >70 years caucasian subjects). Data expressed as mean±SD. 
 
 
The MMSE average score was inferior in the Group II AfD and were similar between Group 
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I AfD and Group II CA. The CDR average score was inferior in the Group II CA and higher in 
the Group II AfD. The QSM average score was higher in the Group I AfD then in Group II  CA 
and lower for Group II AfD. Finally, we refer in this context to age and education because they 
are demographic variables that may influence the performance in neuropsychological tests. 
The Group II AfD presents the higher average age between patients groups (79±5,7); Group 
II CA (76,6±5,3) is the second group with older subjects and the Group I AfD is where the 
lowest average age of patients is concentrated (58,6±5,8). 
Regarding the education level there is a similar average years of education between Groups 
II- AfD (4,4±2,6) and II-CA (4,4±2,1), and the Group I AfD is the one that has the higher 
education average level (7,5±4,0). In a qualitative analysis there does not seem to be much 
disparity between the average neuropsychological scale scores (MMSE; CDR and QSM) since 
they were defined for the study as measures of inclusion criteria. But, on the other hand, it 
seems to be more evident that the group with the lowest average age (Group I AfD: [50- 70] 
years afrodescendent subjects) corresponds to a higher educational level and that the 
groups with the most advanced ages (Group II AfD: >70 years afrodescendent subjects; 



























15 8,7±1,2 3,00 3,6±1,5 1,3±0,9 7,5±0,7 0,5±0,5 
Group II 
AfD 
7 9,3±0,8 3,00 2,4±1,6 1±0,6 7,4±1 0,2±0,5 
Group II 
CA 
7 8,6±1,7 3,00 3,3±1,1 1,3±1,1 8,0±0.0 0,4±0,5 
Table 13. MMSE cognitive subdomains* means scores between patients-groups (Group I AfD: 
50-70age afrodescendent subjects; Group II AfD: >70 age afrodescendent subjects; Group II CA: 
>70 age caucasian subjects); *scores Orientation: 0-10; Retention: 0-3; Attention&Calculation: 0-
5; Recall: 0-3; Language: 0-8 and Constructive_skills:0-1. Data expressed as meanSD. 
Table 13 summarizes the previous MMSE cognitive subdomains scores. In Orientation all 
patient’s groups (Groups I-AfD; II-AfD and II-CA) seems to have a similar average 
performance but the Group II AfD (>70 age caucasian subjects) has the higher average score 
in this subdomain (9,3±0,8). In the Retention subdomain there is no difference between 
groups (3,00).  
In the Attention and Calculation task the Group I AfD as the higher average score (3,6±1,5) 
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then was the Group II CA (3,3±1,1) and Group II AfD (2,4±1,6). In the Recall subdomain 
Groups I-AfD and II-CA have almost the same (average score: ±1,3) and the Group II AFD has 
the lower mean score (1±0,6). The Language competence was similar between Group I AfD 
(7,5±0,7) and Group II AfD (7,4±1), and higher in the Group II CA (8,00). Regarding the 
Constructive skills one more time all the 3 patients-groups seems to have the same average 
score (Group I AfD: 0,5±0,5; Group II AfD: 0,2±0,5 and Group II CA: 0,4±0,5). From the 
qualitative analysis, the most evident differences in mean results are found in the median 
subdomains of evocation and orientation, and these seem to be the ones that most 




























15 0,9±0,4 0,7±0,4 0,5±0,3 0,7±0,3 0,5±0,4 0,3±0,5 
Group II 
AfD 
7 0,9±0,2 0,4±0,4 0,9±0,2 0,9±0,2 0,9±0,2 0,6±0,5 
Group II 
CA 
7 0,9±0,2 0,7±0,3 0,5±0,3 0,5±0,4 0,7±0,3 0,1±0,4 
Table 14 CDR cognitive subdomains* means scores between Patients-groups (Group I AfD: [50-
70 years afrodescendent subjects; Group II AfD: >70 years afrodescendent subjects; Group II 
CA: >70 years caucasian subjects); *(Memory; Orientation; Judgement&Problem Solving; 
Community_affairs; Home&Hobbies and Personal_care, all sub-scores between 0; 0,5; 1; 2 or 3 
qualitative classification sum of boxes). Data expressed as mean±SD. 
 
Table 14 resumes the previous CDR cognitive subdomains results score. The CDR 
subdomains score is not a continuum variable because it’s a qualitative attributive score that 
variates between 0 (no dementia); 0,5 (suspected dementia); 1(mild dementia) and 
2(moderate dementia) and 3 (severe dementia), based on a qualitative clinical-inter- view 
with some neuropsychological tasks. The difference to the MMSE or QSM scores is that in 
CDR a higher score corresponds to a higher cognitive and functional impairment. As we can 
analyze de Memory subdomain was almost the same for the 3 patients-group (mean score: 
0,9).  
The Groups I-AfD and II-CA had the higher mean score in the Orientation questions (0,7±0,4 
and 0,7±0,3 respectively) and the Group II AfD (0,4±0,4) had the lower score. In the 
Judgement & Problem_solving neuropsychological tasks the Group II AfD had the higher 
mean value (0,9±0,2) and the Groups I AfD and II CA the same result (0,5±0,3). The 
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Community_affairs subdomain was higher punctuated by the patients of Group II AfD 
(0,9±0,2), then less punctuated by Group I AfD (0,7±0,3) and in the end with less mean score 
by the Group II CA (0,5±0,4). The Group II achieved a higher mean score in Home&Hobbies 
category with 0,9±0,2 of the results, then the Group II CA with 0,7±0,3 scores and at a lower 
position average the Goup I AfD with 0,5±0,4. At last the Personal_care subdomain was much 
higher in Group II AfD then in Group I AfD (0,3±0,5) and with the lowest mean score the 
Group II CA (0,1±0,4). In the Orientation all the patient’s groups (Groups I-AfD; II-AfD and II-
CA) seem to have a similar average performance but the Group II A (>70 age caucasian 
subjects) had the higher average score in this subdomain (9,3±0,8). In the Retention 
subdomain there is no difference between groups (3,00).  
In the Attention and Calculation task the Group I AfD had the higher average score (3,6±1,5) 
then was the followed by Group II CA (3,3±1,1) and the Group II AfD (2,4±1,6). In the Recall 
subdomain the Groups I-AfD and II-CA had almost the same average score (1,3) and the 
Group II AfD as the lower mean score (1±0,6). The Language competence was similar 
between Group I AfD (7,5±0,7) and Group II AfD (7,4±1), and higher in the Group II CA 
(8,00). Regarding the Constructive skills, again all the 3 patients-groups seems to have the 
same average score (Group I AfD: 0,5±0,5; Group II AfD: 0,2±0,5 and Group II CA: 0,4±0,5). 
From the qualitative analysis, the most evident differences in mean results are found in the 
median subdomains of evocation and orientation, and these seem to be the ones that most 
influenced the total mean MMSE scores between the patient groups. From the qualitative 
analysis, the most evident differences in mean results it seems to be found in the 
Community_affairs; Home&Hobbies and Personal_care between the patient groups. Data 




4.2 Autonomic Evaluation 
 
4.2.1 Cardiovascular variability 
 
Systolic, diastolic arterial pressures and heart rate, at rest, were not different in all groups. 
Regarding autonomic evaluation, our results show that all patients have a lower autonomic 
tone comparing with controls Table 15. In particular, LF and HF show statistically significant 
differences between the three groups (Figs.: 3-5). Regarding general autonomic tone, there 
is a tendency for a decrease with age (Figure 5) with the afrodescendent patients having a 
higher tone than the Caucasians which is in line with the values of resting systolic blood 





Parameter LF (mmHg2) HF (ms2) LF/HF 
AfD [50-70] 
years 
1,80±0,202 32,37±7,430 0,09±0,017 
AfD >70years 1,18±0,303 25,69±5,549 0,07±0.027 
CA >70 years 1,12±0,239 39,95±7,007 0,05±0,023 
Control group 3,6±0,86 94±29,1 2,6±0,55 
Table 15. Values of overall power spectral analysis of heart rate and blood pressure variability 







Figure 3. Comparison of LF power band power, an indication of resting sympathetic activity, 




Afrodescendent (AfD) and Causasian (CA) patients, all aged >70, do not show significant 
changes on sympathetic flow. Younger patients [50-70] have a lower autonomic tone when 
compared with matching controls, the same been observed to aged CA patients while for 
AfD patients the differences to controls are not quite significant probably due to the small 








Figure 4. Significant differences were observed on parasympathetic tone between the patient’s 




Nevertheless, among AfD and AC groups, both aged>70, the parasympathetic outflow was of 
similar magnitude. Between these two groups and despite the age factor which usually 
impacts autonomic evaluation, parasympathetic tone was also not significantly different. * 











Figure 5. Autonomic outflow is significantly reduced in all groups of patients independently of 
age. A tendency is observed for a higher autonomic tone among AfD patients independently of 
the age regarding the CA ones which is in line with blood pressure values at rest. * significant 
between the indicated group and control (p>0.05). Data expressed as mean±SEM. 
 
4.2.2 Baroreceptor reflex study 
 
The evaluation of baroreflex sensitivity or gain (BRS) and its effectiveness (BEI) using the 
sequence method demonstrates an impairment of baroreceptor function in all patient 
groups (Table 16) without any significance difference between them. Baroreflex receptor, 
despite present, shows a delayed response with 100% of all spontaneous baroreflex 









CA>70 years Control 
BEI (%) 32,8±13,3 32,5±12,5 28,2±15,3 70±1,5 
BRS 
(ms/mmHg) 
5,1±3,4 5,2±3,5 6±1,6 19,1±1,6 
Table 16. Values for BEI and BRS for all groups of patients and controls. [50-70] years, n=9; 
DA>70, n=6; CA>70, n=6. Data are presented as mean±SEM. 
 
 
4.2.3 Autonomic provocative manoeuvres 
 
Regarding the autonomic manoeuvres, not all the patients were able to perform them at all 
while others had a deficient performance. Both the difficulty of communication as well the 
age of the patients are reasons for that absence of performance which has consequences on 
data recording and analysis. Nevertheless, the manoeuvre which was better performed was 
deep breathing probably, and beyond the reasons already expressed, because it was the first 
manoeuvre of the evaluation protocol. Thus, results for the 3 manoeuvres-deep breathing, 




 4.2.3.1 Deep Breathing test 
 
 
The deep breathing test is a predominantly parasympathetic manoeuvre as it evaluates 
heart rate responses to changes on respiratory rate being based on the physiological 
mechanism underlying respiratory sinus arrhythmia.  
According to the Ewing testing it is analyzed through the changes of heart rate during the 
manoeuvre. An expiratory/inspiratory (E/I) index  
 
is calculated as if E/I >15, the test is normal but if E/I <15 indicates an impairment of 
parasympathetic system. Representative examples of deep breathing area shown in Figure 















Figure 6. Deep metronomic breathing of four afrodescendent patients extracted from the 
recordings of two patients of each group: [50-70] years (A) and >70 years groups (B). 
 
Where can be observed the difference in the test performance which is age-related but not 
related to the neuropsychological scores. The E/I calculation for [50-70] years is 16,6 and 
10 respectively for the left and right patient indicating a normal and impaired 
parasympathetic outflow. For the patients >70 years old, an increase in the baseline heart 
rate is observed during the test due to the difficulty in performing the test, purpose that 
wasn’t accomplished by the last patient. Indicates the actual starting and end of the test. Red 
lines are indicative markers inserted during the evaluation. 
 
 
4.2.3.2 Valsalva Manouvre 
 
Valsalva manouvre (VM) assesses heart rate and blood pressure changes due to baroreflex 
changes evoked by a respiratory strain. It comprises four phases, two mechanical (I and 









Figure 7. The Valsalva manouvre performed by a patient from the [50-70] group (right panel) 
with a VR=1,1 and BP changes. On the left, an example of a slighty longer manouvre that was 




Regarding the BP changes during VM related to the adrenergic control, it could be observed 
that BP in phase III has values below the resting level indicating an impairment of 
sympathetic activity due to baroreflex dysfunction. Also, despite the normal value of VM, 
some patients also performed the manouvre in a slight longer time. Data shows the presence of all 
the Valsalva phases nevertheless the time for the completion of the manouvre is longer than 
standard 15s used by a control patient. The Valsalva manouvre encompasses four phases, 
two of them due to mechanical effects (I and III) corresponding to the increase and decrease 
of intrathoracic pressure; the other two, are of reflex origin (II and IV); phase II is further 
subdivided into II-e (earlier phase II)when the cardiac output is reduced and the increased 
intrathoracic pressure blocks the venous return to the heart, and phase II-l (late phase II) 
which expresses baroreflex activation, indicates the actual starting and end of the test. Red 





The hand grip test (HG) is a predominantly sympathetic manouvre as it evaluates 
sympathetic activation due to the increase of metabotropic muscle receptors under an 
isomeric contraction. A normal manouvre evokes, at least, an increase of 20mmHg in 





Figure 8. In this figure are shown two HG performed by [50-70] years patient (top) and by a 
patient AfD>70 years (bottom). 
 
 
While the top manoeuver has a normal profile, the lower one is revealing a sympathetic 
impairment due to a deficient rise in diastolic blood pressure with the arrows indicating the 
actual starting and end of the test.  
5. DISCUSSION 
 
Both on clinics and in research, autonomic evaluation through power spectral analysis is 
widely used as a way to qualify and quantify autonomic function. In fact, it has been shown 
that the two main spectral frequencies – low and high frequencies (LF and HF) correlate well 
with the autonomic tone to the periphery. Indeed, LF is influenced by mainly the sympathetic 
tone whereas HF is a quantitative marker of parasympathetic function also being influenced 
by the respiratory rate. The ratio of LF and HF is recognized as the balance of sympathetic 
and parasympathetic activity and represents the overall autonomic tone. 
 
The present pilot study is the first in Portugal addressing the autonomic function in a 
minority population - the afrodescendent population- suffering from mild dementia. Despite 
being a pilot study, our results show a pathologic pattern in the autonomic regulation in 
these patients evaluated through signal processing and Ewing battery of tests. Indeed, a 
decreased autonomic tone as a consequence of a lower sympathetic and parasympathetic a 
together with an impaired baroreflex function was observed.  
 
Overall, our results are in line with previous already published in afro-american populations 
(Liao et al, 1995; Calhoun et al, 1993) with HF and LF/HF ratio being higher in afro 
descendant patients despite having a cognitive impairment, but LF values are varying in an 
opposite way (Giubilei et al, 1998; Zulli et al, 2005; de Vilhena Toledo and Junqueira, 2008). 
Despite believing that this is a novel result as it comes in line with a recent published work of 
Struhal and co-workers in caucasian patients with dementia and neurodegenerative disease 
(Struhal et al, 2016) we may also consider that some of the reasons for this dissonant result 
may be related to the disease itself, to the age of the patients, to a different methodology of 
evaluation, to the patient’s therapeutics or to our small sample size or a combination of a 
few or all of these factors. The reasons why these differences are expressed are not yet 
known but from our study as well from similar ones, it is reinforced that race and age needs to 
be considered when assessing autonomic function. 
 
In our study, we used two different ways of evaluating autonomic testing: a time-scale 
analysis of a basal period and provocative manoeuvres and we noticed that, for this 
population of patients, the former was more effective in collecting autonomic information 
than the second. Indeed, Valsalva maneuver, deep breathing and handgrip need a high 
degree of motivation and cooperation from the patients which may be difficult in aged and 
dement patients even with mild presentations, thus leading to a strong study limitation of 
autonomic function with provocation in this type of patients to avoid false results, results 
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with no consequence and a high rate of drop-outs. In fact, by using signal processing 
independently of the provocative manoeuvres, we were able to show differences between 
the autonomic behavior of the evaluated patients and the controls which is in opposition to 
Nicolini et al (2016) who didn’t find significant differences in mild cognitive patients when 
autonomic evaluation was performed in baseline conditions.  
 
Baroreflex gain or sensitivity (BRS) allows to qualify and quantify the reflex circulatory 
effects which are due to baroreceptor activation on inhibition being an indirect way of, 
through an autonomic reflex, indirectly evaluate the full system. In the present study, we 
observed a reduced baroreceptor responsiveness accompanying mild dementia. BRS was 
evaluated through the sequence method which is based on the spontaneous presence of 
concurrent RR intervals and systolic blood pressure changes (increase or decrease) over 
three consecutives heartbeats. This method allows the assessment of two complementary 
parameters regarding the baroreceptor control of circulation: one, the BRS qualifies the 
information about the baroreceptor sensitivity through the measurement of the reflex 
changes in RR interval in respect to systolic blood pressure reflex changes whereas the 
second, the baroreflex effectiveness index – BEI- gives quantitative information on baroreflex 
function by calculating the number of times the baroreflex is effective in driving the sinus 
node (Di Rienzo et al, 2001; Iacoviello et al, 2008, 2010). In comparison with other indirect 
methods of autonomic evaluation, BRS offers a higher reproducibility in comparison with 
stimulus-dependent methods (mainly with intravenous drugs), it is not dependent from the 
operator and a dynamic assessment of the baroreceptor reflex in short periods (LaRovere et 
al, 2008). It has been previously shown that in response to a quick change in blood pressure 
the relationship between systolic blood pressure and RR-intervals is linear. In our study, it 
was observed a shift of the sequences to lag-2 indicating a strong delay in the chronotropic 
response and suggesting a putative activation of the slow sympathetic activation with the 
deactivation of the fast-vagal response (Malliani, 200; Nollo et al, 2005). If these functional 
changes are due to the disease itself which might be affecting crucial brain stations of the 
central autonomic network or a consequence of patient’s therapeutics and co-morbidities 
which were not discontinued during our study, is still a subject of de- bate which requires 
further investigation. Some studies on autonomic responses to orthostasis have suggested 
that an impaired baroreflex elicits abnormal sympathetic and para- sympathetic responses 






In line with these results, we may hypothesize that, in our study, the baroreflex impairment 
is strongly related to the decrease in autonomic function but mainly in sympathetic activity 
as was observed in autonomic evaluation in the basal period as well as through the delay 
of the Valsalva manoeuvre and the small rise of diastolic blood pressure during hand grip. 
However, since we worked with a reduced sample size, we need to be cautious regarding this 
hypothesis. The relation between baroreflex and cognition has also been studied. In fact, 
previous studies (Yasumasu et al., 2006) show that baroreceptor reflex (BR) sensitivity is 
inhibited during a cognitive performance, and the level of this baroreceptor inhibition was 
negatively and significantly associated with the degree of cognitive performance during 
mental load stress tasks. This supports the existence of a pathway loop mediating mutual 
cardiovascular-central nervous system influences through the baroreceptors, and this 
interaction may be a dynamic mechanism of fundamental importance for cardiovascular 
regulation and an essential mechanism supporting adaptive reactions to stressful conditions. 
In our study we evaluated cognitive measures with neuropsychological tools for the 
inclusive criteria of both afrodescendent and caucasian patients. Another previously and 
specific study suggested that baroreceptor reflex sensitivity is more sensitive to internal 
cognitive elaboration conditions, while baroreflex effectiveness index is more sensitive to 
external attention conditions (del Paso; González & Hernández, 2004). These suggestions 
are in line with our results where a generalized decreased cognitive function is associated 
to baroreflex impairment (both BRS and BEI) and autonomic dysfunction. Whereas BRS and 
/or BEI may be used as marker of therapeutic effectiveness is still a matter of debate but 
some studies already gave some hints on this possibility. In particular, Meelvan and co-
workers suggested BRS as a valid biomarker be- tween cardiovascular disease and AfD 
(Meel-van et al., 2013), because BR is reduced in Alzheimer disease and is influenced by 
autonomic effects of cholinesterase inhibitors (ChEI). These studies have also shown that 
ChEI treatment induced a 66% in BR in Alzheimer patients (Meel-van et al., 2013). Also 
regarding cognitive functions and autonomic function in MCI patients, an early prodromic 
phase of dementia, acetylcholine the main neurotransmitter of the para- sympathetic system 
may be deficient, besides the components of the central autonomic network attract the 
greatest neurofibrillary degeneration and related cell death during the course of AfD and the 
insular cortex and brainstem are affected from the early stages of the disease (Collins et al., 
2012).  
For all these reasons we also believed that further investigation is need to useful despite the 
autonomic dysfunction as a biomarker of neurodegeneration and provides insight into the 
pathophysiological mechanisms that contribute to cognitive decline and may lead to the 
development of effective therapeutic interventions.  
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In a descriptive and qualitative analysis of the neuropsychological data used as a clinical 
reference for the inclusion of our subjects, we observed that in both group-age of patients 
([50-70] and >70years) the score average obtained in MMSE; CDR and QSM were indicative 
of higher functional impairments in cognitive subdomains in the afrodescendent patients 
compared to whites subjects. Especially this mean relation score among the younger age 
[50-70] grouping. In other words, the afrodescendent patients included in this study 
presented the lowest performance in memory and orientation tasks and a higher prevalence 







Regardless being a pilot study, to the best of our knowledge this is the first study based on a 
comprehensive autonomic evaluation by signal processing methodologies and Ewing battery 
manouvres to show autonomic dysfunction, mainly due to the lack of parasympathetic 
reserve, together with a baroreflex impairment in afrodescendent patients, non Caucasian, 
with mild dementia in Portugal.  
 
Despite out of the scope of our work, it might be hypothesized that alterations in the central 
autonomic network beyond those resulting from the aging process, might be underlying the 
observed results. The importance of these results lies on the fact that baroreflex and 
autonomic impairments may be related with the progression of the disease or be an inductor 
of co-morbidities including cardiovascular and orthostatic intolerance which may lead to 
falls, dizziness or even syncopal events in these patients. Also, BRS and /or BEI may be 
considered as valid biomarkers of disease progression of therapeutic effectiveness but 
further research is still needed. Regarding the neuropsychological measures associated with 
the autonomic evaluation of these patients, it would be interesting in future investigations 
with similar methodologies to apply a neuropsychological evaluation protocol not only to 
include or exclude participants based on clinical criteria but to perform a more thorough 
diagnosis at two times, for example (before and after) the autonomic evaluation. In this 
approach it would be also interesting to explore perhaps physiological measures associated 
with emotional states and depressive symptoms; Stress levels or fears and cultural life habits 
related to better characterize and clinical support this Portuguese afrodescendent 
population from the national healthcare system of the municipalities of Amadora and Sintra.  
 
 
6.1 Study limitations 
 
The present study has various limitations some of which may be overcome within further 
work. The most relevant is the sample size. In fact, despite a larger period of sensitization 
and information of the community about the project to facilitate the recruitment of patients 
and their healthy relatives to incorporate a control group, our efforts were somewhat 
unsuccessful. Nevertheless, the acquired knowledge on the dynamics of the minority and 
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A relação investigadora - voluntário participante em projectos de investigação científica é baseada na 
confiança mútua.  
A Faculdade de Medicina de Lisboa (FMUL), o Centro Cardiovascular Universitário de Lisboa (CCUL) e 
o Hospital Prof. Dr. Fernando da Fonseca (HFF) dispõem de procedimentos que permitem 
salvaguardar os direitos de ambos.  
O investigador obriga-se a informar o voluntário participante sobre a natureza da sua participação no 
projecto, potenciais vantagens e inconvenientes, podendo o mesmo aceitar participar ou não 
aceitar participar no projecto proposto. 
Este estudo tem carácter voluntário sendo possível ao participante poder-se retirar em qualquer 
altura, não sendo novos dados adicionados ao estudo e sem que seja prejudicado o seu 
acompanhamento clínico. 
=============================================================================== 
Título do estudo: A Avaliação da função autonómica numa população de doentes afro-descendentes 
com demência ligeira - Um estudo piloto. 
Promotor do estudo (entidade responsável pela execução do projecto): Centro Cardiovascular da 
Universidade de Lisboa - Faculdade de Medicina da Universidade de Lisboa.  
Co-Promotor: Hospital Prof. Dr. Fernando da Fonseca (Serviço de Neurologia). 
Tipo de estudo: Projecto de investigação, prospectivo, realizado em regime de ambulatório. 
Objectivo do projecto: Avaliar a Função Autonómica em Doentes Afro-descendentes de Raça Negra 
com Demência Ligeira, por metodologias não invasivas, de uma população de doentes pertencente 
aos concelhos de Amadora e de Sintra. 
 
Por favor, leia com atenção o presente documento. Se achar que algo está incorrecto ou que 
não está claro, não hesite em solicitar mais informações. Se concorda com a proposta que lhe 
foi feita, queira assinar o documento no seu final e rubricar a primeira página. Este documento 














Enquadramento do estudo:  
Informação com diversas origens é consensual a indicar que o número de pessoas com demência, de 
diferentes etiologias, está a aumentar devido ao envelhecimento da população e à melhoria das 
metodologias diagnósticas. A demência em si não discrimina entre etnias, no entanto, não existem 
em Portugal estudos de base populacional sobre a prevalência e as características de demência numa 
raça ou etnia específica. Por outro lado, os mecanismos subjacentes ao envelhecimento parecem 
estar mais pronunciados em doentes com demência à qual se tem, também, associado, disfunção 
nas estruturas cerebrais que coordenam funções viscerais. Algumas destas estruturas pertencem à 
rede autonómica central. No entanto, a relação entre disautonomia e demência não está ainda bem 
definida para cada etnia. Assim, no âmbito deste estudo piloto, pretendemos investigar a função 
autonómica em doentes negros com demência ligeira diagnosticada clinicamente, de ambos os sexos 
e idade ≥ 50 anos. Após anamnese, história clínica, exame físico e neuropsicológico, a função 
autonómica será avaliada por metodologias no domínio do tempo e no tempo-escala aplicadas às 
variáveis fisiológicas recolhidas durante a Respiração Profunda; Manobra de Valsava e Contracção 
Isotónica. Assim, espera-se com este estudo entender melhor a disfunção autonómica subjacente á 
demência ligeira em doentes de raça negra comparativamente a um grupo de controlo; distinguir 
diferentes mecanismos de progressão da doença entre raça caucasiana e raça negra de uma 
população portuguesa de doentes; contribuir para a caracterização epidemiológica desta população; 
contribuir para a procura de terapêuticas específicas e melhorar o apoio a estes doentes, às suas 
famílias e cuidadores.  
Duração do Estudo (recolha de dados/amostra): Inicio em Fevereiro de 2018 por um período 
previsto de 2 (dois) anos.  
Investigador principal pelo projecto: Isabel Rocha, Professora Universitária-Associada c/Agregação 
da Faculdade de Medicina de Lisboa; Investigadora Principal no CCUL. 
Investigador responsável pelo projecto no Hospital Prof. Doutor Fernando da Fonseca (HFF): Ana 
Valverde, Assistente Graduada de Neurologia (HFF); Investigadora Principal no Centro de Ensaios 
Clínicos de Neurologia (HFF). 
Co-Investigador no HFF e Aluno da FMUL: André Carvalho, Assistente de Neuropsicologia (Serviço 
MFR); Sub-investigador no Centro de Ensaios Clínicos de Neurologia (HFF) e Aluno de Neurociências 
(FMUL) associado ao grupo de Funções Autonómicas Cardiovasculares do CCUL.  
Investigador responsável pelo projecto na Faculdade de Ciências da Universidade de Lisboa (FCUL): 
Hugo Ferreira, Professor Universitário-Auxiliar na FCUL e Investigador Principal no IBEB (Instituto de 












1) Selecção dos doentes (população-alvo) a avaliar: 
1.1 idade ≥50 anos de ambos os sexos, com registo de anos de escolaridade; naturalidade; 
história familiar de demência; dependência de substâncias; hipertensão e dislipidémia. 
1.2 diagnóstico clínico de demência em fase ligeira baseado no DSM-IV-R (Manual 
Diagnóstico e Estatístico de Transtornos Mentais da Associação Americana de 
Psiquiatria). 
1.3 exclusão de doentes que apresentem: diabetes com mau controlo metabólico e/ou 
insulinotratados; doença pulmonar obstrutiva crónica; hipotensão ortostática; síncope 
reflexa; arritmias cardíacas e fibrilação auricular medicados com beta-bloqueantes; 
insuficiência cardíaca moderada a grave; cirurgias cardíacas ou implantes cardíacas; 
medicação bloqueadora beta-adrenérgica ou outras demências secundárias a condições 
orgânicas (ex.: hipotiroidismo, hematoma subdural crónico; asma; esclerose múltipla). 
 
2) Registo pelo processo clinico, quando presente, de valores dos hemogramas de rotina com 
os seguintes doseamentos: HIV; VDRL; Vitamina B12; Acido Fólico e níveis hormonais da 
tiróide. 
 
3) Registo pelo processo clinico, quando presente, da volumetria dos Hipocampos suportado 
por técnicas de neuroimagiologia: TAC-CE ou RM-CE. 
 
4) Aplicação de Medidas Neuropsicológicas para confirmação de Diagnóstico de Demência 
Ligeira, baseadas nos seguintes instrumentos: 
3.1 MMSE (Exame Breve do Estado Mental, com valores normativos referentes a população 
portuguesa): prova de papel e lápis; duração (aproximada): 10 minutos. 
3.2 CDR (Avaliação Clínica da Demência, com valores normativos referentes a população 
portuguesa): entrevista semi-estruturada com cuidador e doente; duração (aproximada) 
30/40 minutos.  
3.3 QSM (Escala de Queixas Subjectivas de Memória, com valores normativos referentes a 
população portuguesa): questionário de auto-avaliação com 10 questões de 
aproximadamente: 5 minutos.  
5) Medição de variáveis cardiovasculares: frequência cardíaca e pressão arterial. A medição da 
frequência cardíaca e da pressão arterial é não invasiva e indolor, ou seja, é feita sem 
utilização de qualquer instrumento que entre na pele e/ou provoque dor. Para isso serão 
colocados, quatro eléctrodos no peito, um sensor no dedo anelar da mão direita e uma 
braçadeira no braço esquerdo. Os sinais registados são enviados para um computador para 








6) Avaliação Autonómica: 20/30 minutos.  
Permite saber como está o estado do sistema nervoso que controla a função de todos os órgãos 
(coração, pulmões, rins, etc). É constituída, neste caso, por três procedimentos: 1.º respiração 
profunda em que se vai respirando mais lentamente a um ritmo específico durante 1 minuto; 2.º 
manobra de Valsalva em que se sopra para um tubo com um certo valor de pressão durante 
15s; e 3.º contracção isométrica em que se faz força com a mão dominante num dinamómetro 
sem o largar, com um certo valor de pressão, durante 5 minutos.  
 
Durante estes procedimentos, a pessoa estará sentada numa cadeira, calma e tranquila, não 
podendo beber café, tomar chá ou fumar nas 12 horas anteriores ao exame. Durante os 
procedimentos será medida a pressão arterial e a frequência cardíaca. Estes procedimentos não 
são invasivos e são indolores, ou seja, são feitos sem utilização de qualquer instrumento que 







Devido à natureza não invasiva do estudo não se esperam inconvenientes para o participante.  
É assegurada a assistência durante o tempo de monitorização, bem como é garantido o livre acesso a 
todas as informações e esclarecimentos adicionais sobre o estudo. 
A equipa de investigação está sujeita a sigilo e confidencialidade. Ou seja, cada participante tem um 
código de identificação que não deixa que o seu nome e/ou identidade seja conhecido.  
Os resultados das medições serão apenas usados para fins científicos. Não resultarão do estudo para 
cada investigador e/ou instituições envolvidas outros benefícios que não os de caracter científico. Ou 












Contactos de E-mail dos Investigadores: 
 
 
§ Dr. André Carvalho (co-responsável no HFF) 
amc.psicologia@gmail.com 




§ Prof.ª Ana Valverde (responsável no HFF) 
ahvalverde82@gmail.com 




§ Profº. Hugo Ferreira (responsável na FCUL/IBEB) 
hatdferreira@gmail.com 
Instituto de Biofísica e Engenharia Biomédica - Faculdade de Ciências da Universidade de 
Lisboa, Campo Grande, 1749-016 Lisboa, Portugal. 
 
 
§ Profª. Isabel Rocha (responsável pelo estudo / CCUL-FMUL) 
isabelrocha0@gmail.com 
Instituto de Fisiologia, Faculdade de Medicina da Universidade de Lisboa, Av. Prof Egas 

























Compreendi a informação que me foi dada, tive oportunidade de fazer perguntas e as minhas dúvidas 
foram esclarecidas. Aceito participar de livre vontade no projecto acima mencionado. Também 
autorizo a divulgação dos resultados obtidos no meio científico, garantindo o anonimato. 
Data: ____ /____ /_______ 
 
Nome do participante (maiúsculas)__________________________________________________ 




Confirmo que expliquei ao participante, de forma adequada e inteligível, os procedimentos, assim 
como os potenciais inconvenientes, e que entreguei o folheto de informação complementar. 
Nome do investigador (maiúsculas)__________________________________________________ 
 
Assinatura do investigador: _________________________________________ 
 
 








Questionário de Avaliação Clínica da Demência 
Esta é uma entrevista semi-estruturada.  Coloque todas as perguntas que se seguem.  Coloque quaisquer outras 
perguntas necessárias para determinar a CDR (Avaliação Clínica da Demência) do doente.  Anote as informações 
das perguntas adicionais. 
Perguntas sobre a memória para o informante (pessoa próxima do doente): 
1. O doente tem problemas de memória ou raciocínio? Sim Não 
1a. Se respondeu sim, o problema é constante (no sentido oposto de inconstante)? Sim Não 
2. O doente consegue lembrar-se de acontecimentos recentes? Geralmente Às vezes Raramente 
3. O doente consegue memorizar uma pequena lista de coisas
(compras)? Geralmente  Às vezes Raramente 
4. Verificou-se algum declínio na memória ao longo do último ano? Sim Não 
5. A memória do doente apresenta limitações ao ponto destas poderem ter
interferido com as suas actividades do dia-a-dia há alguns anos (ou
durante a sua vida activa)? (opinião de pessoas próximas do doente) Sim  Não 
6. O doente esquece-se completamente de um acontecimento
importante (por exemplo, viagem, festa, casamento de
família) a algumas semanas do acontecimento? Geralmente Às vezes Raramente 
7. O doente esquece-se de pormenores marcantes desse
acontecimento importante? Geralmente Às vezes Raramente 
8. O doente esquece-se completamente de informações importantes
do passado distante (por exemplo, data de nascimento,
data de casamento, local de emprego)? Geralmente Às vezes Raramente 
9. Fale-me de um acontecimento recente na vida do doente do qual ele se deveria lembrar.  (Obtenha
pormenores tais como o local do acontecimento, hora, convidados, duração, quando acabou e como o doente
ou outros convidados chegaram lá, para posterior comparação com as respostas do doente).
No espaço de 1 semana: 
No espaço de 1 mês: 
10. Quando é que o doente nasceu?
11. Onde é que o doente nasceu?




13. Qual foi a ocupação/emprego principal do doente (ou emprego do parceiro, caso o doente
não tivesse emprego)?
14. Qual foi o último emprego principal do doente (ou emprego do parceiro, caso o doente não tivesse
emprego)?











Questionário de Avaliação Clínica da Demência 
Perguntas sobre a orientação para o informante: 
Com que frequência sabe o doente exactamente: 
1. O dia do mês?
Geralmente Às vezes Raramente Não sei 
2. O mês?
Geralmente Às vezes Raramente Não sei 
3. O ano?
Geralmente Às vezes Raramente Não sei 
4. O dia da semana?
Geralmente Às vezes Raramente Não sei 
5. O doente tem dificuldades de orientação em relação ao tempo (situar os acontecimentos no tempo)?
Geralmente Às vezes Raramente Não sei 
6. O doente consegue orientar-se em ruas que lhe são familiares?
Geralmente Às vezes Raramente Não sei 
7. Com que frequência sabe ele/ela como deslocar-se de um local para o outro, fora da sua área de residência?
Geralmente Às vezes Raramente Não sei 
8. Com que frequência consegue o doente orientar-se dentro de casa?







Questionário de Avaliação Clínica da Demência 
Perguntas sobre o discernimento e resolução de problemas para o informante: 
1. De um modo geral, se tivesse de avaliar a capacidade do doente para resolver problemas presentemente,
consideraria essa capacidade:
Tão boa como no passado 




2. Avalie a capacidade do doente para lidar com pequenas quantias de dinheiro (por exemplo, calcular trocos,
deixar uma pequena gorjeta):
Nenhuma perda de capacidade 
Alguma perda de capacidade 
Grave perda de capacidade 
3. Avalie a capacidade do doente para lidar com assuntos financeiros ou comerciais complicados (por exemplo,
verificar o livro de cheques, pagar contas):
Nenhuma perda de capacidade 
Alguma perda de capacidade 
Grave perda de capacidade 
4. O doente consegue lidar com uma pequena emergência doméstica (por exemplo, fuga de água nas
canalizações, pequeno incêndio)?
Tão bem como antes 
Pior do que antes, devido às dificuldades de raciocínio 
Pior do que antes, outra razão (porquê)
5. O doente consegue compreender situações ou explicações?
Geralmente Às vezes Raramente Não sei 
6. O doente comporta-se* de forma adequada [isto é, no seu estado habitual (pré-mórbido)] em situações
sociais e interacções com outras pessoas?
Geralmente Às vezes Raramente Não sei 
________________________ 







Questionário de Avaliação Clínica da Demência 
Perguntas sobre o relacionamento com a comunidade para o informante: 
Trabalho 
1. O doente ainda trabalha? Sim Não N/A 
Se não for aplicável, prossiga para a pergunta 4 
Se respondeu Sim, prossiga para a pergunta 3 
Se respondeu Não, prossiga para a pergunta 2 
2. Os problemas de memória ou raciocínio contribuíram para a decisão do
doente em se reformar?  (A pergunta 4 é a seguinte) Sim Não N/S 
3. O doente tem dificuldades significativas no emprego, devido aos problemas de memória ou raciocínio?
Raramente ou nunca Às vezes Geralmente Não sei 
Vida social 
4. O doente já alguma vez conduziu? Sim Não 
O doente conduz actualmente? Sim Não 
Se respondeu Não, é devido aos problemas de memória ou raciocínio? Sim Não 
5. Se o doente ainda conduz, verificam-se problemas ou riscos devido a um
raciocínio insuficiente? Sim Não 
*6. O doente consegue fazer compras sozinho?
Raramente ou nunca Às vezes Geralmente Não sei
(Tem de ser acompanhado (Compra apenas um número limitado
em qualquer ida às compras) de coisas; compra coisas a dobrar 
ou esquece-se de coisas necessárias) 
7. O doente consegue realizar actividades fora de casa sozinho?
Raramente ou nunca Às vezes Geralmente Não sei
(De um modo geral não é (Participação limitada  (Participação 
capaz de realizar actividades e/ou rotineira, por   activa em 
sem ajuda) exemplo, participação  actividades,  
superficial em actividades  por exemplo,  
religiosas ou reuniões;  votações) 
idas ao cabeleireiro) 
8. O doente envolveu-se em funções sociais fora de casa? Sim Não 
Se respondeu Não, porque não?
9. Avaliando o comportamento do doente, um observador casual diria que o doente
está doente? Sim Não 
10. Caso se encontre num lar de terceira idade, o doente participa activamente em
funções sociais (raciocínio)? Sim Não 
IMPORTANTE: 
Existem informações suficientes para avaliar o nível de limitação do doente nas actividades em comunidade? 
Se respondeu Não, tente obter mais informações. 
Relacionamento com a comunidade:  Tais como actividades religiosas, visitas a amigos ou familiares, actividades 
políticas, organizações profissionais, como a associação de advogados, outros grupos profissionais, clubes, 
organizações de serviços, programas educativos. 
_______________________ 







Questionário de Avaliação Clínica da Demência 
Perguntas sobre as actividades domésticas e passatempos para o informante: 
1a.  Que alterações ocorreram na capacidade do doente em realizar tarefas domésticas? 
1b.  Quais são as tarefas que o doente ainda faz bem?
2a.  Quais são as alterações verificadas na capacidade do doente em realizar passatempos? 
2b.  Quais são os passatempos que o doente ainda realiza bem?
3. Caso se encontre num lar de terceira idade, quais são as actividades que o doente já não faz bem (tarefas
domésticas e passatempos)?
Actividades do dia-a-dia (The Dementia Scale of Blessed): 
Nenhuma perda Grave perda  
de capacidade de capacidade 
4. Capacidade de desempenhar tarefas
domésticas 0 0,5 1 
Descreva:
5. O doente tem capacidade para realizar tarefas ao nível de:
(Seleccione uma resposta.  Não é necessário perguntar directamente ao informante).
Nenhum funcionamento significativo. 
(Realiza actividades simples, como fazer a cama, apenas com muita supervisão) 
Funciona apenas em actividades limitadas. 
(Com alguma supervisão, lava a loiça com uma eficiência aceitável; põe a mesa) 
Funciona de forma independente em algumas actividades. 
(Utiliza aparelhos, como um aspirador; prepara refeições simples) 
Funciona em actividades habituais, mas não ao nível habitual. 
Funciona normalmente em actividades habituais. 
IMPORTANTE: 
Existem informações suficientes para avaliar o nível de limitação do doente nas actividades domésticas e 
passatempos? 
Se respondeu Não, tente obter mais informações. 
Tarefas Domésticas:  Como cozinhar, tratar da roupa, limpar, fazer compras, levar o lixo à rua, trabalhar no 
quintal, realizar tarefas simples de manutenção e reparações domésticas básicas. 
Passatempos:  Costura, pintura, trabalhos manuais, leitura, entretenimento, fotografia, jardinagem, assistir a 







Questionário de Avaliação Clínica da Demência 
Perguntas sobre os cuidados pessoais para o informante: 





Sequência errada, peças 
frequentemente 
esquecidas









Às vezes necessita 
de ajuda
Necessita sempre 
ou quase sempre de 
ajuda
B. Lavar-se, arranjar-se 0 1 2 3







Tem de ser 
alimentado
C. Hábitos alimentares 0 1 2 3
Controlo completo 
normal   
Às vezes urina  
na cama








0 1 2 3
__________________________________ 
* Pode ser considerada a classificação de 1, se os cuidados pessoais do doente estiverem limitados face a







Questionário de Avaliação Clínica da Demência 
Perguntas sobre a memória para o doente: 
1. Tem problemas de memória ou raciocínio? Sim Não 
2. Há poucos instantes, o seu (parceiro, etc.) contou-me um acontecimento que se passou recentemente. Quer
contar-me o que aconteceu? (Se for necessário, obtenha pormenores tais como o local, hora, pessoas
envolvidas, qual foi a duração, quando acabou e como o doente ou outras pessoas chegaram lá).
No espaço de 1 semana
1,0 – Correcto (em grande parte) 
0,5
0,0 – Incorrecto (em grande 
 parte) 
No espaço de 1 mês
1,0 – Correcto (em grande parte) 
0,5
0,0 – Incorrecto (em grande 
 parte) 
3. Vou dar-lhe um nome e um endereço para memorizar durante alguns minutos.  Repita este nome e endereço:
(Repita até a frase ser repetida correctamente ou até um máximo de três tentativas).
Elementos 1 2 3 4 5
João Borges, Rua do Mercado, 42 Guimarães
João Borges, Rua do Mercado, 42 Guimarães
João Borges, Rua do Mercado, 42 Guimarães
(Sublinhe os elementos repetidos de forma correcta em cada uma das tentativas). 
4. Quando nasceu?
5. Onde nasceu?
6. Qual foi a última escola que frequentou?
Nome
Cidade Classe
7. Qual foi a sua ocupação/emprego principal (ou
do seu parceiro, caso não tivesse emprego)?
8. Qual foi o seu último emprego principal (ou
do seu parceiro, caso não tivesse emprego)?
9. Quando se reformou (ou o seu parceiro) e porquê?
10. Repita o nome e endereço que lhe pedi para memorizar:
Elementos 1 2 3 4 5 
João Borges, Rua do Mercado, 42 Guimarães







Questionário de Avaliação Clínica da Demência 
Perguntas sobre a orientação para o doente: 
Registe literalmente a resposta do doente a cada pergunta 
1. Qual é a data de hoje? Correcto Incorrecto 
2. Qual é o dia da semana? Correcto Incorrecto 
3. Qual é o mês? Correcto Incorrecto 
4. Qual é o ano? Correcto Incorrecto 
5. Qual é o nome deste local? Correcto Incorrecto 
6. Em que terra nos encontramos? Correcto Incorrecto 
7. Que horas são? Correcto Incorrecto 







Questionário de Avaliação Clínica da Demência 
Perguntas sobre o discernimento e resolução de problemas para o doente: 
Instruções:  Caso a resposta inicial do doente não mereça uma avaliação de 0, insista no assunto para 
identificar o melhor entendimento do problema por parte do doente.  Marque com um círculo a resposta que 
mais se aproxima. 
Semelhanças: 
Exemplo:  “Em que aspecto se assemelha um lápis a uma caneta?  (instrumentos de escrita) 
Em que aspecto se assemelham estas coisas?” Resposta do doente 
1. nabo……couve-flor
 (0 = vegetais) 
(1 = alimentos comestíveis, seres vivos, podem ser cozinhados, etc.) 
(2 = respostas não pertinentes; diferenças; compram-se)
2. escrivaninha……estante de livros
(0 = mobiliário, mobiliário de escritório; ambos servem para guardar livros) 
(1 = em madeira, pernas)
(2 = não pertinentes; diferenças)
Diferenças: 
Exemplo: “Qual é a diferença entre açúcar e vinagre?  (doce vs. azedo) 
Qual é a diferença entre estas coisas?” 
3. mentira……erro
(0 = um é intencional, o outro não)
(1 = um é mau, o outro é bom – ou explica apenas um)
(2 = tudo o resto, semelhanças)
4. rio……canal
(0 = natural - artificial)
(2 = tudo o resto) 
Cálculos: 
5. Quantas moedas de 5 cêntimos perfazem um euro? Correcto Incorrecto 
6. Quantas moedas de 50 cêntimos perfazem 15,50 euros?  Correcto Incorrecto 
7. Subtraia 3 a 20 e continue a subtrair 3 a
cada número novo até ao fim. Correcto Incorrecto 
Discernimento: 
8. Depois de chegar a uma cidade que não conhece, de que forma tentaria localizar um amigo
que gostaria de visitar?
(0 = tentar a lista telefónica; telefonar a um amigo comum)
(1 = telefonar à polícia, telefonar para as Informações (normalmente não facultam endereços)
(2 = nenhuma resposta clara)
9. Avaliação do doente relativamente à sua incapacidade e posição na vida e a sua percepção
das razões porque está presente neste exame (mesmo que já tenha avaliado este aspecto,
classifique aqui):








AVALIAÇÃO CLÍNICA DA DEMÊNCIA (CDR) 
AVALIAÇÃO CLÍNICA DA 













Nenhuma perda de memória 




parcial dos acontecimentos; 
esquecimento "benigno" 
Perda de memória 
moderada; mais acentuada 
nos acontecimentos 
recentes; interfere com as 
actividades do dia-a-dia
Perda de memória grave; 
apenas memorização de 
material retido com 
insistência; rápida perda de 
material novo
Perda de memória grave; 
restam apenas fragmentos
Orientação
Bem orientado Bem orientado com ligeira 
dificuldade nas relações 
temporais
Dificuldade moderada nas 
relações temporais; 




Dificuldade grave nas 
relações temporais; quase 
sempre desorientado no 
tempo, frequentemente no 
espaço
Orientado apenas em 




Resolve problemas do dia-a-
dia, lida bem com actividades 
financeiras e de negócio; bom 
discernimento em relação a 
desempenhos no passado




para resolver problemas, 
semelhanças e diferenças; 
normalmente mantém o 
discernimento social
Limitação grave para resolver 
problemas, semelhanças e 
diferenças; normalmente o 
discernimento social é 
limitado
Incapacidade de 






ao nível habitual no trabalho, 
compras, grupos de 
voluntariado e outros
Ligeira limitação nestas 
actividades
Incapaz de funcionar 
independentemente nestas 
actividades, embora, de 
certa forma, ainda possa 
estar envolvido; numa 
avaliação superficial 
aparenta normalidade
Incapacidade de funcionamento independente fora de casa
Aparenta estar 
suficientemente bem para 
realizar funções fora de casa
Aparenta estar demasiado 




Vida em casa, passatempos e 
interesses intelectuais bem 
preservados
Vida em casa, passatempos 
e interesses intelectuais 
ligeiramente limitados
Limitação ligeira, mas 
evidente, do funcionamento 
em casa; abandono das 
tarefas mais difíceis; 
abandono dos passatempos 
e interesses mais 
complicados
Preservado apenas o 
interesse nas tarefas simples; 
interesses muito restritos e 
fracos
Nenhuma capacidade 




Inteiramente capaz de cuidar de si próprio Necessita de instruções Necessita de ajuda para se 
vestir, para a higiene e para 
manter objectos pessoais
Necessita de muita ajuda 
com os cuidados pessoais; 
incontinência frequente





                                                                                                                                                                                                        
M INI-MENTAL STATE EXAM E 
 
NOME: ________________________ _____________ 
 
IDADE: _____ ANOS                                      DATA: _____ de ______________ de  ________ 
 
1. ORIENTAÇÃO (1 ponto por cada resposta correcta). 
Em que ano estamos?    _________ 
Em que mês estamos?   _________ 
Em que dia do mês estamos?   _________ 
 Em que dia da semana estamos?  _________ 
 Em que estação do ano estamos?  _________ 
 Em que país estamos?   _________  
 Em que distrito vive?    _________ 
 Em que terra vive?    _________ 
 Em que casa estamos?   _________ 
 Em que andar estamos?   _________   
 
2. RETENÇÃO (contar 1 ponto por cada palavra correctamente repetida). 
“Vou dizer três palavras; queria que as repetisse, mas só depois de eu as dizer 
todas; procure ficar a sabê-las de cór”.   
Pêra      __________ 
Gato      __________ 
Bola      __________  
 
3. ATENÇÃO E CÁLCULO (1 ponto por cada resposta correcta. Se der uma errada mas depois 
continuar a subtrair bem, consideram-se as seguintes como correctas. Parar ao fim de 5 
respostas.) 
“Agora peço-lhe que me diga quantos são 30 menos 3 e depois ao número 
encontrado volta a tirar 3 e repete assim até eu lhe dizer para parar”. 
 
27 ____    24 ____    21 ____    18 ____    15 ____  
 
4. EVOCAÇÃO (1 ponto por cada resposta correcta). 
“Veja se consegue dizer as três palavras que pedi há pouco para decorar”. 
  
Pêra      __________ 
Gato      __________ 
Bola      __________  
 
5. LINGUAGEM (1 ponto por cada resposta correcta) 
a. “Como se chama isto? Mostrar objectos: 
Relógio    __________ 
Lápis     __________  
 
b. “Repita a frase que eu vou dizer: O RATO ROEU A ROLHA” 
 
c. “Quando eu lhe der esta folha de papel, pegue nela com a mão direita, dobre-a 
ao meio e coloque-a no chão”, (ou “sobre a cama”, se for o caso); dar a folha 
segurando com as duas mãos. 
 
Pega com a mão direita  __________ 
Dobra ao meio   __________ 
Coloca no chão   __________  
 
d. “Leia o que está neste cartão e faça o que lá diz”. Mostrar um cartão com a 
frase bem legível, “FECHE OS OLHOS” sendo analfabeto ler-se a frase. 
Fechou os olhos 
 
 
e. “Escreva uma frase inteira aqui”. Deve ter sujeito e verbo e fazer sentido; os 






















6. HABILIDADE CONSTRUTIVA (1 ponto pela cópia correcta) 
Deve copiar um desenho. Dois pentágonos parcialmente sobrepostos; cada um deve 



















       CÓPIA  
 
 




























ESCALA DE QUEIXAS SUBJECTIVAS DE MEMÓRIA (QSM) 
 
1. Tem queixas acerca da sua memória? 
0 – Não 
1 – Sim, mas sem importância 
2 – Sim, com alguma importância 
3 – Sim, com problemas 
2. Já lhe disseram que o(a) acham esquecido(a)? 
0 – Não 
1 – Sim, por vezes 
2 – Sim, frequentemente 
3. Esquece com frequência nomes de pessoas da família ou de amigos? 
0 – Não 
1 – Sim, mas sem importância 
2 – Sim, com alguma importância 
3 – Sim, com problemas 
4. Esquece-se frequentemente onde põe as coisas? 
0 – Não 
1 – Sim, mas sem importância 
2 – Sim, com alguma importância 
3 – Sim, com problemas 
5. Costuma tomar apontamentos para não se esquecer das coisas? 
0 – Não 
1 – Sim, por vezes 
2 – sim, frequentemente 
6. A conversar costuma ter dificuldades em encontrar as palavras? 
0 – Não 
1 – Sim 
7. Já alguma vez se perdeu perto de sua casa? 
0 – Não 
1 – Sim 
8. Acha que anda a pensar mais devagar do que antes? 
0 – Não 
1 – Sim 
2 – Sim, com problemas 
9. Sente que as suas ideias por vezes ficam confusas (baralhadas)? 
0 – Não 
1 – Sim 












10. Tem tido dificuldades em concentrar-se? 
0 – Não 
1 – Sim 
2 – Sim, com problemas 
Total: _____ 
! Auto-aplicação 
! Hetero-aplicação. Motivo? ____________ 
